id	sid	tid	token	lemma	pos
ajlm-1597	1	1	abstract	abstract	ADJ
ajlm-1597	1	2	introduction	introduction	NOUN
ajlm-1597	1	3	methods	method	NOUN
ajlm-1597	1	4	results	result	VERB
ajlm-1597	1	5	discussion	discussion	NOUN
ajlm-1597	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1597	1	7	references	reference	NOUN
ajlm-1597	1	8	about	about	ADP
ajlm-1597	1	9	the	the	DET
ajlm-1597	1	10	author(s	author(s	NOUN
ajlm-1597	1	11	)	)	PUNCT
ajlm-1597	1	12	vuyolwethu	vuyolwethu	PROPN
ajlm-1597	1	13	fadana	fadana	PROPN
ajlm-1597	1	14	school	school	NOUN
ajlm-1597	1	15	of	of	ADP
ajlm-1597	1	16	pathology	pathology	NOUN
ajlm-1597	1	17	,	,	PUNCT
ajlm-1597	1	18	faculty	faculty	NOUN
ajlm-1597	1	19	of	of	ADP
ajlm-1597	1	20	health	health	NOUN
ajlm-1597	1	21	sciences	sciences	PROPN
ajlm-1597	1	22	,	,	PUNCT
ajlm-1597	1	23	university	university	NOUN
ajlm-1597	1	24	of	of	ADP
ajlm-1597	1	25	the	the	DET
ajlm-1597	1	26	witwatersrand	witwatersrand	NOUN
ajlm-1597	1	27	,	,	PUNCT
ajlm-1597	1	28	johannesburg	johannesburg	PROPN
ajlm-1597	1	29	,	,	PUNCT
ajlm-1597	1	30	south	south	PROPN
ajlm-1597	1	31	africa	africa	PROPN
ajlm-1597	1	32	department	department	PROPN
ajlm-1597	1	33	pathology	pathology	PROPN
ajlm-1597	1	34	,	,	PUNCT
ajlm-1597	1	35	national	national	PROPN
ajlm-1597	1	36	health	health	PROPN
ajlm-1597	1	37	laboratory	laboratory	PROPN
ajlm-1597	1	38	services	services	PROPN
ajlm-1597	1	39	,	,	PUNCT
ajlm-1597	1	40	johannesburg	johannesburg	PROPN
ajlm-1597	1	41	,	,	PUNCT
ajlm-1597	1	42	south	south	PROPN
ajlm-1597	1	43	africa	africa	PROPN
ajlm-1597	1	44	teena	teena	PROPN
ajlm-1597	1	45	thomas	thomas	PROPN
ajlm-1597	1	46	school	school	PROPN
ajlm-1597	1	47	of	of	ADP
ajlm-1597	1	48	pathology	pathology	PROPN
ajlm-1597	1	49	,	,	PUNCT
ajlm-1597	1	50	faculty	faculty	NOUN
ajlm-1597	1	51	of	of	ADP
ajlm-1597	1	52	health	health	NOUN
ajlm-1597	1	53	sciences	sciences	PROPN
ajlm-1597	1	54	,	,	PUNCT
ajlm-1597	1	55	university	university	NOUN
ajlm-1597	1	56	of	of	ADP
ajlm-1597	1	57	the	the	DET
ajlm-1597	1	58	witwatersrand	witwatersrand	NOUN
ajlm-1597	1	59	,	,	PUNCT
ajlm-1597	1	60	johannesburg	johannesburg	PROPN
ajlm-1597	1	61	,	,	PUNCT
ajlm-1597	1	62	south	south	PROPN
ajlm-1597	1	63	africa	africa	PROPN
ajlm-1597	1	64	infectious	infectious	ADJ
ajlm-1597	1	65	control	control	PROPN
ajlm-1597	1	66	services	service	NOUN
ajlm-1597	1	67	laboratory	laboratory	NOUN
ajlm-1597	1	68	,	,	PUNCT
ajlm-1597	1	69	national	national	PROPN
ajlm-1597	1	70	health	health	PROPN
ajlm-1597	1	71	laboratory	laboratory	PROPN
ajlm-1597	1	72	services	services	PROPN
ajlm-1597	1	73	,	,	PUNCT
ajlm-1597	1	74	johannesburg	johannesburg	PROPN
ajlm-1597	1	75	,	,	PUNCT
ajlm-1597	1	76	south	south	PROPN
ajlm-1597	1	77	africa	africa	PROPN
ajlm-1597	1	78	nina	nina	PROPN
ajlm-1597	1	79	von	von	PROPN
ajlm-1597	1	80	knorring	knorre	VERB
ajlm-1597	1	81	school	school	NOUN
ajlm-1597	1	82	of	of	ADP
ajlm-1597	1	83	pathology	pathology	NOUN
ajlm-1597	1	84	,	,	PUNCT
ajlm-1597	1	85	faculty	faculty	NOUN
ajlm-1597	1	86	of	of	ADP
ajlm-1597	1	87	health	health	NOUN
ajlm-1597	1	88	sciences	sciences	PROPN
ajlm-1597	1	89	,	,	PUNCT
ajlm-1597	1	90	university	university	NOUN
ajlm-1597	1	91	of	of	ADP
ajlm-1597	1	92	the	the	DET
ajlm-1597	1	93	witwatersrand	witwatersrand	NOUN
ajlm-1597	1	94	,	,	PUNCT
ajlm-1597	1	95	johannesburg	johannesburg	PROPN
ajlm-1597	1	96	,	,	PUNCT
ajlm-1597	1	97	south	south	PROPN
ajlm-1597	1	98	africa	africa	PROPN
ajlm-1597	1	99	mycobacteriology	mycobacteriology	PROPN
ajlm-1597	1	100	referral	referral	PROPN
ajlm-1597	1	101	laboratory	laboratory	NOUN
ajlm-1597	1	102	,	,	PUNCT
ajlm-1597	1	103	national	national	PROPN
ajlm-1597	1	104	health	health	PROPN
ajlm-1597	1	105	laboratory	laboratory	PROPN
ajlm-1597	1	106	service	service	PROPN
ajlm-1597	1	107	,	,	PUNCT
ajlm-1597	1	108	johannesburg	johannesburg	PROPN
ajlm-1597	1	109	,	,	PUNCT
ajlm-1597	1	110	south	south	PROPN
ajlm-1597	1	111	africa	africa	PROPN
ajlm-1597	1	112	citation	citation	PROPN
ajlm-1597	1	113	fadana	fadana	PROPN
ajlm-1597	1	114	v	v	PROPN
ajlm-1597	1	115	,	,	PUNCT
ajlm-1597	1	116	thomas	thomas	PROPN
ajlm-1597	1	117	t	t	PROPN
ajlm-1597	1	118	,	,	PUNCT
ajlm-1597	1	119	von	von	PROPN
ajlm-1597	1	120	knorring	knorre	VERB
ajlm-1597	1	121	n.	n.	PROPN
ajlm-1597	1	122	retrospective	retrospective	ADJ
ajlm-1597	1	123	analysis	analysis	NOUN
ajlm-1597	1	124	of	of	ADP
ajlm-1597	1	125	vitek	vitek	PROPN
ajlm-1597	1	126	®	®	PROPN
ajlm-1597	1	127	2	2	NUM
ajlm-1597	1	128	performance	performance	NOUN
ajlm-1597	1	129	compared	compare	VERB
ajlm-1597	1	130	to	to	ADP
ajlm-1597	1	131	manual	manual	ADJ
ajlm-1597	1	132	broth	broth	ADJ
ajlm-1597	1	133	micro	micro	NOUN
ajlm-1597	1	134	-	-	NOUN
ajlm-1597	1	135	dilution	dilution	NOUN
ajlm-1597	1	136	for	for	ADP
ajlm-1597	1	137	colistin	colistin	NOUN
ajlm-1597	1	138	susceptibility	susceptibility	NOUN
ajlm-1597	1	139	testing	testing	NOUN
ajlm-1597	1	140	of	of	ADP
ajlm-1597	1	141	acinetobacter	acinetobacter	ADJ
ajlm-1597	1	142	baumannii	baumannii	ADJ
ajlm-1597	1	143	complex	complex	ADJ
ajlm-1597	1	144	isolates	isolate	NOUN
ajlm-1597	1	145	in	in	ADP
ajlm-1597	1	146	south	south	PROPN
ajlm-1597	1	147	africa	africa	PROPN
ajlm-1597	1	148	.	.	PUNCT
ajlm-1597	2	1	afr	afr	PROPN
ajlm-1597	2	2	j	j	PROPN
ajlm-1597	2	3	lab	lab	PROPN
ajlm-1597	2	4	med	med	PROPN
ajlm-1597	2	5	.	.	PUNCT
ajlm-1597	3	1	2022;11(1	2022;11(1	NUM
ajlm-1597	3	2	)	)	PUNCT
ajlm-1597	3	3	,	,	PUNCT
ajlm-1597	3	4	a1597	a1597	PROPN
ajlm-1597	3	5	.	.	PUNCT
ajlm-1597	3	6	https://doi.org/10.4102/ajlm.v11i1.1597	https://doi.org/10.4102/ajlm.v11i1.1597	PROPN
ajlm-1597	3	7	brief	brief	PROPN
ajlm-1597	3	8	report	report	NOUN
ajlm-1597	3	9	retrospective	retrospective	ADJ
ajlm-1597	3	10	analysis	analysis	NOUN
ajlm-1597	3	11	of	of	ADP
ajlm-1597	3	12	vitek	vitek	PROPN
ajlm-1597	3	13	®	®	PROPN
ajlm-1597	3	14	2	2	NUM
ajlm-1597	3	15	performance	performance	NOUN
ajlm-1597	3	16	compared	compare	VERB
ajlm-1597	3	17	to	to	ADP
ajlm-1597	3	18	manual	manual	ADJ
ajlm-1597	3	19	broth	broth	ADJ
ajlm-1597	3	20	micro	micro	NOUN
ajlm-1597	3	21	-	-	NOUN
ajlm-1597	3	22	dilution	dilution	NOUN
ajlm-1597	3	23	for	for	ADP
ajlm-1597	3	24	colistin	colistin	NOUN
ajlm-1597	3	25	susceptibility	susceptibility	NOUN
ajlm-1597	3	26	testing	testing	NOUN
ajlm-1597	3	27	of	of	ADP
ajlm-1597	3	28	acinetobacter	acinetobacter	ADJ
ajlm-1597	3	29	baumanniicomplex	baumanniicomplex	NOUN
ajlm-1597	3	30	isolates	isolate	NOUN
ajlm-1597	3	31	in	in	ADP
ajlm-1597	3	32	south	south	PROPN
ajlm-1597	3	33	africa	africa	PROPN
ajlm-1597	3	34	vuyolwethu	vuyolwethu	PROPN
ajlm-1597	3	35	fadana	fadana	PROPN
ajlm-1597	3	36	,	,	PUNCT
ajlm-1597	3	37	teena	teena	PROPN
ajlm-1597	3	38	thomas	thomas	PROPN
ajlm-1597	3	39	,	,	PUNCT
ajlm-1597	3	40	nina	nina	PROPN
ajlm-1597	3	41	von	von	PROPN
ajlm-1597	3	42	knorring	knorring	PROPN
ajlm-1597	3	43	received	receive	VERB
ajlm-1597	3	44	:	:	PUNCT
ajlm-1597	3	45	29	29	NUM
ajlm-1597	3	46	mar	mar	PROPN
ajlm-1597	3	47	.	.	PROPN
ajlm-1597	3	48	2021	2021	NUM
ajlm-1597	3	49	;	;	PUNCT
ajlm-1597	3	50	accepted	accept	VERB
ajlm-1597	3	51	:	:	PUNCT
ajlm-1597	3	52	27	27	NUM
ajlm-1597	3	53	oct	oct	NOUN
ajlm-1597	3	54	.	.	PROPN
ajlm-1597	3	55	2021	2021	NUM
ajlm-1597	3	56	;	;	PUNCT
ajlm-1597	3	57	published	publish	VERB
ajlm-1597	3	58	:	:	PUNCT
ajlm-1597	3	59	28	28	NUM
ajlm-1597	3	60	feb	feb	X
ajlm-1597	3	61	.	.	PROPN
ajlm-1597	4	1	2022	2022	NUM
ajlm-1597	4	2	copyright	copyright	NOUN
ajlm-1597	4	3	:	:	PUNCT
ajlm-1597	4	4	©	©	PROPN
ajlm-1597	4	5	2022	2022	NUM
ajlm-1597	4	6	.	.	PUNCT
ajlm-1597	5	1	the	the	DET
ajlm-1597	5	2	author(s	author(s	PROPN
ajlm-1597	5	3	)	)	PUNCT
ajlm-1597	5	4	.	.	PUNCT
ajlm-1597	6	1	licensee	licensee	NOUN
ajlm-1597	6	2	:	:	PUNCT
ajlm-1597	6	3	aosis	aosis	NOUN
ajlm-1597	6	4	.	.	PUNCT
ajlm-1597	7	1	this	this	PRON
ajlm-1597	7	2	is	be	AUX
ajlm-1597	7	3	an	an	DET
ajlm-1597	7	4	open	open	ADJ
ajlm-1597	7	5	access	access	NOUN
ajlm-1597	7	6	article	article	NOUN
ajlm-1597	7	7	distributed	distribute	VERB
ajlm-1597	7	8	under	under	ADP
ajlm-1597	7	9	the	the	DET
ajlm-1597	7	10	terms	term	NOUN
ajlm-1597	7	11	of	of	ADP
ajlm-1597	7	12	the	the	DET
ajlm-1597	7	13	creative	creative	ADJ
ajlm-1597	7	14	commons	common	NOUN
ajlm-1597	7	15	attribution	attribution	NOUN
ajlm-1597	7	16	license	license	NOUN
ajlm-1597	7	17	,	,	PUNCT
ajlm-1597	7	18	which	which	PRON
ajlm-1597	7	19	permits	permit	VERB
ajlm-1597	7	20	unrestricted	unrestricted	ADJ
ajlm-1597	7	21	use	use	NOUN
ajlm-1597	7	22	,	,	PUNCT
ajlm-1597	7	23	distribution	distribution	NOUN
ajlm-1597	7	24	,	,	PUNCT
ajlm-1597	7	25	and	and	CCONJ
ajlm-1597	7	26	reproduction	reproduction	NOUN
ajlm-1597	7	27	in	in	ADP
ajlm-1597	7	28	any	any	DET
ajlm-1597	7	29	medium	medium	NOUN
ajlm-1597	7	30	,	,	PUNCT
ajlm-1597	7	31	provided	provide	VERB
ajlm-1597	7	32	the	the	DET
ajlm-1597	7	33	original	original	ADJ
ajlm-1597	7	34	work	work	NOUN
ajlm-1597	7	35	is	be	AUX
ajlm-1597	7	36	properly	properly	ADV
ajlm-1597	7	37	cited	cite	VERB
ajlm-1597	7	38	.	.	PUNCT
ajlm-1597	8	1	abstract	abstract	ADJ
ajlm-1597	8	2	the	the	DET
ajlm-1597	8	3	manual	manual	ADJ
ajlm-1597	8	4	broth	broth	ADJ
ajlm-1597	8	5	micro	micro	NOUN
ajlm-1597	8	6	-	-	NOUN
ajlm-1597	8	7	dilution	dilution	NOUN
ajlm-1597	8	8	(	(	PUNCT
ajlm-1597	8	9	mbmd	mbmd	NOUN
ajlm-1597	8	10	)	)	PUNCT
ajlm-1597	8	11	is	be	AUX
ajlm-1597	8	12	the	the	DET
ajlm-1597	8	13	recommended	recommend	VERB
ajlm-1597	8	14	reference	reference	NOUN
ajlm-1597	8	15	method	method	NOUN
ajlm-1597	8	16	for	for	ADP
ajlm-1597	8	17	colistin	colistin	NOUN
ajlm-1597	8	18	minimum	minimum	NOUN
ajlm-1597	8	19	inhibitory	inhibitory	ADJ
ajlm-1597	8	20	concentration	concentration	NOUN
ajlm-1597	8	21	determination	determination	NOUN
ajlm-1597	8	22	;	;	PUNCT
ajlm-1597	8	23	however	however	ADV
ajlm-1597	8	24	,	,	PUNCT
ajlm-1597	8	25	it	it	PRON
ajlm-1597	8	26	is	be	AUX
ajlm-1597	8	27	not	not	PART
ajlm-1597	8	28	as	as	ADV
ajlm-1597	8	29	readily	readily	ADV
ajlm-1597	8	30	available	available	ADJ
ajlm-1597	8	31	in	in	ADP
ajlm-1597	8	32	south	south	PROPN
ajlm-1597	8	33	africa	africa	PROPN
ajlm-1597	8	34	as	as	ADP
ajlm-1597	8	35	the	the	DET
ajlm-1597	8	36	vitek	vitek	PROPN
ajlm-1597	8	37	®	®	PROPN
ajlm-1597	8	38	2	2	NUM
ajlm-1597	8	39	.	.	PUNCT
ajlm-1597	9	1	this	this	DET
ajlm-1597	9	2	retrospective	retrospective	ADJ
ajlm-1597	9	3	study	study	NOUN
ajlm-1597	9	4	compared	compare	VERB
ajlm-1597	9	5	the	the	DET
ajlm-1597	9	6	performance	performance	NOUN
ajlm-1597	9	7	of	of	ADP
ajlm-1597	9	8	vitek	vitek	PROPN
ajlm-1597	9	9	®	®	PROPN
ajlm-1597	9	10	2	2	NUM
ajlm-1597	9	11	against	against	ADP
ajlm-1597	9	12	mbmd	mbmd	NOUN
ajlm-1597	9	13	in	in	ADP
ajlm-1597	9	14	determining	determine	VERB
ajlm-1597	9	15	the	the	DET
ajlm-1597	9	16	colistin	colistin	NOUN
ajlm-1597	9	17	minimum	minimum	NOUN
ajlm-1597	9	18	inhibitory	inhibitory	ADJ
ajlm-1597	9	19	concentration	concentration	NOUN
ajlm-1597	9	20	of	of	ADP
ajlm-1597	9	21	337	337	NUM
ajlm-1597	9	22	extensively	extensively	ADV
ajlm-1597	9	23	drug	drug	NOUN
ajlm-1597	9	24	-	-	PUNCT
ajlm-1597	9	25	resistant	resistant	ADJ
ajlm-1597	9	26	acinetobacter	acinetobact	ADJ
ajlm-1597	9	27	baumannii	baumannii	ADJ
ajlm-1597	9	28	complex	complex	ADJ
ajlm-1597	9	29	isolates	isolate	NOUN
ajlm-1597	9	30	.	.	PUNCT
ajlm-1597	10	1	vitek	vitek	PROPN
ajlm-1597	10	2	®	®	PROPN
ajlm-1597	10	3	2	2	NUM
ajlm-1597	10	4	yielded	yield	VERB
ajlm-1597	10	5	a	a	DET
ajlm-1597	10	6	categorical	categorical	ADJ
ajlm-1597	10	7	agreement	agreement	NOUN
ajlm-1597	10	8	of	of	ADP
ajlm-1597	10	9	89	89	NUM
ajlm-1597	10	10	%	%	NOUN
ajlm-1597	10	11	,	,	PUNCT
ajlm-1597	10	12	an	an	DET
ajlm-1597	10	13	essential	essential	ADJ
ajlm-1597	10	14	agreement	agreement	NOUN
ajlm-1597	10	15	of	of	ADP
ajlm-1597	10	16	56	56	NUM
ajlm-1597	10	17	%	%	NOUN
ajlm-1597	10	18	,	,	PUNCT
ajlm-1597	10	19	a	a	DET
ajlm-1597	10	20	major	major	ADJ
ajlm-1597	10	21	error	error	NOUN
ajlm-1597	10	22	rate	rate	NOUN
ajlm-1597	10	23	of	of	ADP
ajlm-1597	10	24	8	8	NUM
ajlm-1597	10	25	%	%	NOUN
ajlm-1597	10	26	and	and	CCONJ
ajlm-1597	10	27	a	a	DET
ajlm-1597	10	28	very	very	ADV
ajlm-1597	10	29	major	major	ADJ
ajlm-1597	10	30	error	error	NOUN
ajlm-1597	10	31	rate	rate	NOUN
ajlm-1597	10	32	of	of	ADP
ajlm-1597	10	33	55	55	NUM
ajlm-1597	10	34	%	%	NOUN
ajlm-1597	10	35	.	.	PUNCT
ajlm-1597	11	1	the	the	DET
ajlm-1597	11	2	vitek	vitek	PROPN
ajlm-1597	11	3	®	®	PROPN
ajlm-1597	11	4	2	2	NUM
ajlm-1597	11	5	is	be	AUX
ajlm-1597	11	6	not	not	PART
ajlm-1597	11	7	an	an	DET
ajlm-1597	11	8	alternative	alternative	NOUN
ajlm-1597	11	9	to	to	ADP
ajlm-1597	11	10	mbmd	mbmd	NOUN
ajlm-1597	11	11	for	for	ADP
ajlm-1597	11	12	colistin	colistin	NOUN
ajlm-1597	11	13	susceptibility	susceptibility	NOUN
ajlm-1597	11	14	testing	testing	NOUN
ajlm-1597	11	15	.	.	PUNCT
ajlm-1597	12	1	keywords	keyword	NOUN
ajlm-1597	12	2	:	:	PUNCT
ajlm-1597	12	3	acinetobacter	acinetobacter	ADV
ajlm-1597	12	4	;	;	PUNCT
ajlm-1597	12	5	colistin	colistin	PROPN
ajlm-1597	12	6	;	;	PUNCT
ajlm-1597	12	7	broth	broth	ADJ
ajlm-1597	12	8	micro	micro	NOUN
ajlm-1597	12	9	-	-	NOUN
ajlm-1597	12	10	dilution	dilution	NOUN
ajlm-1597	12	11	;	;	PUNCT
ajlm-1597	12	12	vitek	vitek	PROPN
ajlm-1597	12	13	®	®	PROPN
ajlm-1597	12	14	2	2	NUM
ajlm-1597	12	15	;	;	PUNCT
ajlm-1597	12	16	antimicrobial	antimicrobial	ADJ
ajlm-1597	12	17	susceptibility	susceptibility	NOUN
ajlm-1597	12	18	testing	testing	NOUN
ajlm-1597	12	19	.	.	PUNCT
ajlm-1597	13	1	introduction	introduction	NOUN
ajlm-1597	13	2	the	the	DET
ajlm-1597	13	3	increasing	increase	VERB
ajlm-1597	13	4	antimicrobial	antimicrobial	ADJ
ajlm-1597	13	5	resistance	resistance	NOUN
ajlm-1597	13	6	in	in	ADP
ajlm-1597	13	7	the	the	DET
ajlm-1597	13	8	acinetobacter	acinetobacter	ADJ
ajlm-1597	13	9	baumannii	baumannii	ADJ
ajlm-1597	13	10	complex	complex	NOUN
ajlm-1597	13	11	,	,	PUNCT
ajlm-1597	13	12	and	and	CCONJ
ajlm-1597	13	13	the	the	DET
ajlm-1597	13	14	recently	recently	ADV
ajlm-1597	13	15	observed	observe	VERB
ajlm-1597	13	16	resistance	resistance	NOUN
ajlm-1597	13	17	to	to	ADP
ajlm-1597	13	18	the	the	DET
ajlm-1597	13	19	polymyxin	polymyxin	ADJ
ajlm-1597	13	20	antibiotic	antibiotic	NOUN
ajlm-1597	13	21	(	(	PUNCT
ajlm-1597	13	22	colistin	colistin	PROPN
ajlm-1597	13	23	)	)	PUNCT
ajlm-1597	13	24	,	,	PUNCT
ajlm-1597	13	25	demands	demand	VERB
ajlm-1597	13	26	timeous	timeous	ADJ
ajlm-1597	13	27	identification	identification	NOUN
ajlm-1597	13	28	and	and	CCONJ
ajlm-1597	13	29	antimicrobial	antimicrobial	ADJ
ajlm-1597	13	30	susceptibility	susceptibility	NOUN
ajlm-1597	13	31	profiling	profiling	NOUN
ajlm-1597	13	32	of	of	ADP
ajlm-1597	13	33	causal	causal	ADJ
ajlm-1597	13	34	pathogens	pathogen	NOUN
ajlm-1597	13	35	to	to	PART
ajlm-1597	13	36	ensure	ensure	VERB
ajlm-1597	13	37	timely	timely	ADJ
ajlm-1597	13	38	and	and	CCONJ
ajlm-1597	13	39	appropriate	appropriate	ADJ
ajlm-1597	13	40	antimicrobial	antimicrobial	ADJ
ajlm-1597	13	41	therapy	therapy	NOUN
ajlm-1597	13	42	decisions.1,2	decisions.1,2	PROPN
ajlm-1597	13	43	different	different	ADJ
ajlm-1597	13	44	laboratory	laboratory	NOUN
ajlm-1597	13	45	methods	method	NOUN
ajlm-1597	13	46	for	for	ADP
ajlm-1597	13	47	the	the	DET
ajlm-1597	13	48	assessment	assessment	NOUN
ajlm-1597	13	49	of	of	ADP
ajlm-1597	13	50	colistin	colistin	NOUN
ajlm-1597	13	51	susceptibility	susceptibility	NOUN
ajlm-1597	13	52	testing	testing	NOUN
ajlm-1597	13	53	among	among	ADP
ajlm-1597	13	54	a.	a.	NOUN
ajlm-1597	13	55	baumannii	baumannii	PROPN
ajlm-1597	13	56	isolates	isolate	NOUN
ajlm-1597	13	57	have	have	AUX
ajlm-1597	13	58	been	be	AUX
ajlm-1597	13	59	assessed.3	assessed.3	NOUN
ajlm-1597	13	60	since	since	SCONJ
ajlm-1597	13	61	2016	2016	NUM
ajlm-1597	13	62	,	,	PUNCT
ajlm-1597	13	63	the	the	DET
ajlm-1597	13	64	reference	reference	NOUN
ajlm-1597	13	65	colistin	colistin	VERB
ajlm-1597	13	66	susceptibility	susceptibility	NOUN
ajlm-1597	13	67	testing	testing	NOUN
ajlm-1597	13	68	method	method	NOUN
ajlm-1597	13	69	recommended	recommend	VERB
ajlm-1597	13	70	by	by	ADP
ajlm-1597	13	71	the	the	DET
ajlm-1597	13	72	clinical	clinical	ADJ
ajlm-1597	13	73	and	and	CCONJ
ajlm-1597	13	74	laboratory	laboratory	NOUN
ajlm-1597	13	75	standards	standard	NOUN
ajlm-1597	13	76	institute	institute	PROPN
ajlm-1597	13	77	and	and	CCONJ
ajlm-1597	13	78	the	the	DET
ajlm-1597	13	79	european	european	PROPN
ajlm-1597	13	80	committee	committee	PROPN
ajlm-1597	13	81	on	on	ADP
ajlm-1597	13	82	antimicrobial	antimicrobial	ADJ
ajlm-1597	13	83	susceptibility	susceptibility	NOUN
ajlm-1597	13	84	testing	testing	NOUN
ajlm-1597	13	85	is	be	AUX
ajlm-1597	13	86	the	the	DET
ajlm-1597	13	87	international	international	ADJ
ajlm-1597	13	88	organization	organization	NOUN
ajlm-1597	13	89	for	for	ADP
ajlm-1597	13	90	standardization	standardization	NOUN
ajlm-1597	13	91	(	(	PUNCT
ajlm-1597	13	92	iso	iso	NOUN
ajlm-1597	13	93	)	)	PUNCT
ajlm-1597	13	94	broth	broth	NOUN
ajlm-1597	13	95	micro	micro	NOUN
ajlm-1597	13	96	-	-	NOUN
ajlm-1597	13	97	dilution	dilution	NOUN
ajlm-1597	13	98	(	(	PUNCT
ajlm-1597	13	99	bmd	bmd	PROPN
ajlm-1597	13	100	)	)	PUNCT
ajlm-1597	13	101	method	method	NOUN
ajlm-1597	13	102	(	(	PUNCT
ajlm-1597	13	103	iso-20776).4	iso-20776).4	NOUN
ajlm-1597	13	104	implementing	implement	VERB
ajlm-1597	13	105	manual	manual	ADJ
ajlm-1597	13	106	bmd	bmd	PROPN
ajlm-1597	13	107	(	(	PUNCT
ajlm-1597	13	108	mbmd	mbmd	PROPN
ajlm-1597	13	109	)	)	PUNCT
ajlm-1597	13	110	is	be	AUX
ajlm-1597	13	111	currently	currently	ADV
ajlm-1597	13	112	not	not	PART
ajlm-1597	13	113	feasible	feasible	ADJ
ajlm-1597	13	114	in	in	ADP
ajlm-1597	13	115	the	the	DET
ajlm-1597	13	116	routine	routine	ADJ
ajlm-1597	13	117	microbiology	microbiology	NOUN
ajlm-1597	13	118	laboratory	laboratory	NOUN
ajlm-1597	13	119	due	due	ADP
ajlm-1597	13	120	to	to	ADP
ajlm-1597	13	121	its	its	PRON
ajlm-1597	13	122	laborious	laborious	ADJ
ajlm-1597	13	123	nature.5	nature.5	NOUN
ajlm-1597	13	124	the	the	DET
ajlm-1597	13	125	vitek	vitek	PROPN
ajlm-1597	13	126	®	®	PROPN
ajlm-1597	13	127	2	2	NUM
ajlm-1597	13	128	(	(	PUNCT
ajlm-1597	13	129	biomerieux	biomerieux	PROPN
ajlm-1597	13	130	inc	inc	PROPN
ajlm-1597	13	131	.	.	PROPN
ajlm-1597	13	132	,	,	PUNCT
ajlm-1597	13	133	marcy	marcy	PROPN
ajlm-1597	13	134	l’étoile	l’étoile	PROPN
ajlm-1597	13	135	,	,	PUNCT
ajlm-1597	13	136	france	france	PROPN
ajlm-1597	13	137	)	)	PUNCT
ajlm-1597	13	138	is	be	AUX
ajlm-1597	13	139	an	an	DET
ajlm-1597	13	140	automated	automate	VERB
ajlm-1597	13	141	microbial	microbial	ADJ
ajlm-1597	13	142	identification	identification	NOUN
ajlm-1597	13	143	and	and	CCONJ
ajlm-1597	13	144	antimicrobial	antimicrobial	ADJ
ajlm-1597	13	145	susceptibility	susceptibility	NOUN
ajlm-1597	13	146	testing	testing	NOUN
ajlm-1597	13	147	(	(	PUNCT
ajlm-1597	13	148	ast	ast	NOUN
ajlm-1597	13	149	)	)	PUNCT
ajlm-1597	13	150	platform	platform	NOUN
ajlm-1597	13	151	.	.	PUNCT
ajlm-1597	14	1	most	most	ADJ
ajlm-1597	14	2	public	public	ADJ
ajlm-1597	14	3	and	and	CCONJ
ajlm-1597	14	4	private	private	ADJ
ajlm-1597	14	5	south	south	ADJ
ajlm-1597	14	6	african	african	ADJ
ajlm-1597	14	7	laboratories	laboratory	NOUN
ajlm-1597	14	8	use	use	VERB
ajlm-1597	14	9	the	the	DET
ajlm-1597	14	10	vitek	vitek	PROPN
ajlm-1597	14	11	®	®	PROPN
ajlm-1597	14	12	2	2	NUM
ajlm-1597	14	13	,	,	PUNCT
ajlm-1597	14	14	making	make	VERB
ajlm-1597	14	15	it	it	PRON
ajlm-1597	14	16	an	an	DET
ajlm-1597	14	17	attractive	attractive	ADJ
ajlm-1597	14	18	alternative	alternative	NOUN
ajlm-1597	14	19	to	to	ADP
ajlm-1597	14	20	the	the	DET
ajlm-1597	14	21	mbmd	mbmd	NOUN
ajlm-1597	14	22	.	.	PUNCT
ajlm-1597	15	1	however	however	ADV
ajlm-1597	15	2	,	,	PUNCT
ajlm-1597	15	3	studies	study	NOUN
ajlm-1597	15	4	comparing	compare	VERB
ajlm-1597	15	5	vitek	vitek	PROPN
ajlm-1597	15	6	®	®	PROPN
ajlm-1597	15	7	2	2	NUM
ajlm-1597	15	8	and	and	CCONJ
ajlm-1597	15	9	the	the	DET
ajlm-1597	15	10	mbmd	mbmd	ADJ
ajlm-1597	15	11	method	method	NOUN
ajlm-1597	15	12	have	have	AUX
ajlm-1597	15	13	reported	report	VERB
ajlm-1597	15	14	discordant	discordant	ADJ
ajlm-1597	15	15	colistin	colistin	NOUN
ajlm-1597	15	16	susceptibility	susceptibility	NOUN
ajlm-1597	15	17	results	result	NOUN
ajlm-1597	15	18	.	.	PUNCT
ajlm-1597	16	1	dafopoulou	dafopoulou	PROPN
ajlm-1597	16	2	et	et	PROPN
ajlm-1597	16	3	al	al	PROPN
ajlm-1597	16	4	.	.	PROPN
ajlm-1597	16	5	compared	compare	VERB
ajlm-1597	16	6	the	the	DET
ajlm-1597	16	7	mbmd	mbmd	NOUN
ajlm-1597	16	8	with	with	ADP
ajlm-1597	16	9	polysorbate-80	polysorbate-80	PROPN
ajlm-1597	16	10	,	,	PUNCT
ajlm-1597	16	11	vitek	vitek	PROPN
ajlm-1597	16	12	®	®	PROPN
ajlm-1597	16	13	2	2	NUM
ajlm-1597	16	14	,	,	PUNCT
ajlm-1597	16	15	etest	et	ADJ
ajlm-1597	16	16	,	,	PUNCT
ajlm-1597	16	17	agar	agar	NOUN
ajlm-1597	16	18	dilution	dilution	NOUN
ajlm-1597	16	19	,	,	PUNCT
ajlm-1597	16	20	and	and	CCONJ
ajlm-1597	16	21	the	the	DET
ajlm-1597	16	22	minimum	minimum	ADJ
ajlm-1597	16	23	inhibitory	inhibitory	ADJ
ajlm-1597	16	24	concentration	concentration	NOUN
ajlm-1597	16	25	(	(	PUNCT
ajlm-1597	16	26	mic	mic	ADJ
ajlm-1597	16	27	)	)	PUNCT
ajlm-1597	16	28	methods	method	NOUN
ajlm-1597	16	29	for	for	ADP
ajlm-1597	16	30	the	the	DET
ajlm-1597	16	31	colistin	colistin	NOUN
ajlm-1597	16	32	susceptibility	susceptibility	NOUN
ajlm-1597	16	33	testing	testing	NOUN
ajlm-1597	16	34	of	of	ADP
ajlm-1597	16	35	51	51	NUM
ajlm-1597	16	36	klebsiella	klebsiella	NOUN
ajlm-1597	16	37	pneumoniae	pneumoniae	NOUN
ajlm-1597	16	38	and	and	CCONJ
ajlm-1597	16	39	20	20	NUM
ajlm-1597	16	40	a.	a.	NOUN
ajlm-1597	16	41	baumannii	baumannii	PROPN
ajlm-1597	16	42	clinical	clinical	ADJ
ajlm-1597	16	43	isolates.6	isolates.6	PROPN
ajlm-1597	16	44	eighteen	eighteen	NUM
ajlm-1597	16	45	of	of	ADP
ajlm-1597	16	46	the	the	DET
ajlm-1597	16	47	a.	a.	NOUN
ajlm-1597	16	48	baumannii	baumannii	PROPN
ajlm-1597	16	49	isolates	isolate	NOUN
ajlm-1597	16	50	were	be	AUX
ajlm-1597	16	51	colistin	colistin	NOUN
ajlm-1597	16	52	-	-	PUNCT
ajlm-1597	16	53	resistant	resistant	ADJ
ajlm-1597	16	54	by	by	ADP
ajlm-1597	16	55	mbmd	mbmd	NOUN
ajlm-1597	16	56	,	,	PUNCT
ajlm-1597	16	57	and	and	CCONJ
ajlm-1597	16	58	vitek	vitek	PROPN
ajlm-1597	16	59	®	®	PROPN
ajlm-1597	16	60	2	2	NUM
ajlm-1597	16	61	categorically	categorically	ADV
ajlm-1597	16	62	agreed	agree	VERB
ajlm-1597	16	63	in	in	ADP
ajlm-1597	16	64	85	85	NUM
ajlm-1597	16	65	%	%	NOUN
ajlm-1597	16	66	and	and	CCONJ
ajlm-1597	16	67	essentially	essentially	ADV
ajlm-1597	16	68	agreed	agree	VERB
ajlm-1597	16	69	in	in	ADP
ajlm-1597	16	70	90	90	NUM
ajlm-1597	16	71	%	%	NOUN
ajlm-1597	16	72	of	of	ADP
ajlm-1597	16	73	the	the	DET
ajlm-1597	16	74	a.	a.	NOUN
ajlm-1597	16	75	baumannii	baumannii	PROPN
ajlm-1597	16	76	isolates	isolate	NOUN
ajlm-1597	16	77	.	.	PUNCT
ajlm-1597	17	1	there	there	PRON
ajlm-1597	17	2	were	be	VERB
ajlm-1597	17	3	no	no	DET
ajlm-1597	17	4	‘	'	PUNCT
ajlm-1597	17	5	very	very	ADV
ajlm-1597	17	6	major	major	ADJ
ajlm-1597	17	7	errors	error	NOUN
ajlm-1597	17	8	’	'	PUNCT
ajlm-1597	17	9	(	(	PUNCT
ajlm-1597	17	10	vme	vme	PROPN
ajlm-1597	17	11	)	)	PUNCT
ajlm-1597	17	12	reported	report	VERB
ajlm-1597	17	13	.	.	PUNCT
ajlm-1597	18	1	these	these	DET
ajlm-1597	18	2	findings	finding	NOUN
ajlm-1597	18	3	were	be	AUX
ajlm-1597	18	4	similar	similar	ADJ
ajlm-1597	18	5	to	to	ADP
ajlm-1597	18	6	those	those	PRON
ajlm-1597	18	7	obtained	obtain	VERB
ajlm-1597	18	8	by	by	ADP
ajlm-1597	18	9	lo	lo	PROPN
ajlm-1597	18	10	-	-	PUNCT
ajlm-1597	18	11	ten	ten	NUM
ajlm-1597	18	12	-	-	PUNCT
ajlm-1597	18	13	foe	foe	NOUN
ajlm-1597	18	14	et	et	NOUN
ajlm-1597	18	15	al.7	al.7	PROPN
ajlm-1597	18	16	piewngam	piewngam	PROPN
ajlm-1597	18	17	and	and	CCONJ
ajlm-1597	18	18	kiratisin	kiratisin	PROPN
ajlm-1597	18	19	also	also	ADV
ajlm-1597	18	20	observed	observe	VERB
ajlm-1597	18	21	a	a	DET
ajlm-1597	18	22	low	low	ADJ
ajlm-1597	18	23	vme	vme	NOUN
ajlm-1597	18	24	rate	rate	NOUN
ajlm-1597	18	25	of	of	ADP
ajlm-1597	18	26	0.7	0.7	NUM
ajlm-1597	18	27	%	%	NOUN
ajlm-1597	18	28	when	when	SCONJ
ajlm-1597	18	29	testing	test	VERB
ajlm-1597	18	30	290	290	NUM
ajlm-1597	18	31	a.	a.	NOUN
ajlm-1597	18	32	baumannii	baumannii	NOUN
ajlm-1597	18	33	isolates.8	isolates.8	PROPN
ajlm-1597	18	34	these	these	DET
ajlm-1597	18	35	findings	finding	NOUN
ajlm-1597	18	36	suggest	suggest	VERB
ajlm-1597	18	37	that	that	SCONJ
ajlm-1597	18	38	vitek	vitek	PROPN
ajlm-1597	18	39	®	®	PROPN
ajlm-1597	18	40	2	2	NUM
ajlm-1597	18	41	could	could	AUX
ajlm-1597	18	42	be	be	AUX
ajlm-1597	18	43	a	a	DET
ajlm-1597	18	44	viable	viable	ADJ
ajlm-1597	18	45	alternative	alternative	NOUN
ajlm-1597	18	46	to	to	ADP
ajlm-1597	18	47	the	the	DET
ajlm-1597	18	48	mbmd	mbmd	NOUN
ajlm-1597	18	49	.	.	PUNCT
ajlm-1597	19	1	in	in	ADP
ajlm-1597	19	2	contrast	contrast	NOUN
ajlm-1597	19	3	to	to	ADP
ajlm-1597	19	4	these	these	DET
ajlm-1597	19	5	results	result	NOUN
ajlm-1597	19	6	,	,	PUNCT
ajlm-1597	19	7	vourli	vourli	NOUN
ajlm-1597	19	8	et	et	PROPN
ajlm-1597	19	9	al	al	PROPN
ajlm-1597	19	10	.	.	PROPN
ajlm-1597	19	11	reported	report	VERB
ajlm-1597	19	12	unacceptably	unacceptably	ADV
ajlm-1597	19	13	high	high	ADJ
ajlm-1597	19	14	vme	vme	PROPN
ajlm-1597	19	15	rates	rate	NOUN
ajlm-1597	19	16	for	for	ADP
ajlm-1597	19	17	phoenix100	phoenix100	PROPN
ajlm-1597	19	18	and	and	CCONJ
ajlm-1597	19	19	vitek	vitek	PROPN
ajlm-1597	19	20	®	®	PROPN
ajlm-1597	19	21	2	2	NUM
ajlm-1597	19	22	against	against	ADP
ajlm-1597	19	23	the	the	DET
ajlm-1597	19	24	mbmd	mbmd	NOUN
ajlm-1597	19	25	(	(	PUNCT
ajlm-1597	19	26	41.4	41.4	NUM
ajlm-1597	19	27	%	%	NOUN
ajlm-1597	19	28	and	and	CCONJ
ajlm-1597	19	29	37.9%).9	37.9%).9	NUM
ajlm-1597	19	30	additionally	additionally	ADV
ajlm-1597	19	31	,	,	PUNCT
ajlm-1597	19	32	in	in	ADP
ajlm-1597	19	33	2017	2017	NUM
ajlm-1597	19	34	biomerieux	biomerieux	NOUN
ajlm-1597	19	35	retracted	retract	VERB
ajlm-1597	19	36	the	the	DET
ajlm-1597	19	37	use	use	NOUN
ajlm-1597	19	38	of	of	ADP
ajlm-1597	19	39	vitek	vitek	PROPN
ajlm-1597	19	40	®	®	PROPN
ajlm-1597	19	41	2	2	NUM
ajlm-1597	19	42	for	for	ADP
ajlm-1597	19	43	colistin	colistin	NOUN
ajlm-1597	19	44	testing	testing	NOUN
ajlm-1597	19	45	owing	owe	VERB
ajlm-1597	19	46	to	to	ADP
ajlm-1597	19	47	the	the	DET
ajlm-1597	19	48	clinical	clinical	ADJ
ajlm-1597	19	49	and	and	CCONJ
ajlm-1597	19	50	laboratory	laboratory	NOUN
ajlm-1597	19	51	standards	standard	NOUN
ajlm-1597	19	52	institute	institute	PROPN
ajlm-1597	19	53	-	-	PUNCT
ajlm-1597	19	54	european	european	PROPN
ajlm-1597	19	55	committee	committee	PROPN
ajlm-1597	19	56	on	on	ADP
ajlm-1597	19	57	antimicrobial	antimicrobial	ADJ
ajlm-1597	19	58	susceptibility	susceptibility	NOUN
ajlm-1597	19	59	testing	testing	NOUN
ajlm-1597	19	60	recommendations	recommendation	NOUN
ajlm-1597	19	61	and	and	CCONJ
ajlm-1597	19	62	an	an	DET
ajlm-1597	19	63	in	in	ADP
ajlm-1597	19	64	-	-	PUNCT
ajlm-1597	19	65	house	house	NOUN
ajlm-1597	19	66	observed	observe	VERB
ajlm-1597	19	67	performance	performance	NOUN
ajlm-1597	19	68	issue	issue	NOUN
ajlm-1597	19	69	:	:	PUNCT
ajlm-1597	19	70	high	high	ADJ
ajlm-1597	19	71	vme	vme	PROPN
ajlm-1597	19	72	rate	rate	NOUN
ajlm-1597	19	73	against	against	ADP
ajlm-1597	19	74	agar	agar	NOUN
ajlm-1597	19	75	dilution	dilution	NOUN
ajlm-1597	19	76	and	and	CCONJ
ajlm-1597	19	77	mbmd	mbmd	NOUN
ajlm-1597	19	78	methods.10	methods.10	NOUN
ajlm-1597	19	79	due	due	ADP
ajlm-1597	19	80	to	to	ADP
ajlm-1597	19	81	these	these	DET
ajlm-1597	19	82	contradictory	contradictory	ADJ
ajlm-1597	19	83	findings	finding	NOUN
ajlm-1597	19	84	in	in	ADP
ajlm-1597	19	85	the	the	DET
ajlm-1597	19	86	literature	literature	NOUN
ajlm-1597	19	87	,	,	PUNCT
ajlm-1597	19	88	further	further	ADJ
ajlm-1597	19	89	research	research	NOUN
ajlm-1597	19	90	into	into	ADP
ajlm-1597	19	91	this	this	DET
ajlm-1597	19	92	area	area	NOUN
ajlm-1597	19	93	was	be	AUX
ajlm-1597	19	94	warranted	warrant	VERB
ajlm-1597	19	95	.	.	PUNCT
ajlm-1597	20	1	this	this	DET
ajlm-1597	20	2	study	study	NOUN
ajlm-1597	20	3	aimed	aim	VERB
ajlm-1597	20	4	to	to	PART
ajlm-1597	20	5	compare	compare	VERB
ajlm-1597	20	6	the	the	DET
ajlm-1597	20	7	performance	performance	NOUN
ajlm-1597	20	8	of	of	ADP
ajlm-1597	20	9	vitek	vitek	PROPN
ajlm-1597	20	10	®	®	PROPN
ajlm-1597	20	11	2	2	NUM
ajlm-1597	20	12	colistin	colistin	NOUN
ajlm-1597	20	13	susceptibility	susceptibility	NOUN
ajlm-1597	20	14	testing	testing	NOUN
ajlm-1597	20	15	to	to	ADP
ajlm-1597	20	16	mbmd	mbmd	NOUN
ajlm-1597	20	17	for	for	ADP
ajlm-1597	20	18	clinical	clinical	ADJ
ajlm-1597	20	19	extensively	extensively	ADV
ajlm-1597	20	20	drug	drug	NOUN
ajlm-1597	20	21	-	-	PUNCT
ajlm-1597	20	22	resistant	resistant	ADJ
ajlm-1597	20	23	(	(	PUNCT
ajlm-1597	20	24	xdr	xdr	PROPN
ajlm-1597	20	25	)	)	PUNCT
ajlm-1597	20	26	a.	a.	NOUN
ajlm-1597	20	27	baumannii	baumannii	PROPN
ajlm-1597	20	28	complex	complex	ADJ
ajlm-1597	20	29	isolates	isolate	NOUN
ajlm-1597	20	30	at	at	ADP
ajlm-1597	20	31	charlotte	charlotte	PROPN
ajlm-1597	20	32	maxeke	maxeke	PROPN
ajlm-1597	20	33	johannesburg	johannesburg	PROPN
ajlm-1597	20	34	academic	academic	ADJ
ajlm-1597	20	35	hospital	hospital	PROPN
ajlm-1597	20	36	in	in	ADP
ajlm-1597	20	37	johannesburg	johannesburg	PROPN
ajlm-1597	20	38	,	,	PUNCT
ajlm-1597	20	39	south	south	PROPN
ajlm-1597	20	40	africa	africa	PROPN
ajlm-1597	20	41	.	.	PUNCT
ajlm-1597	21	1	methods	method	NOUN
ajlm-1597	21	2	ethical	ethical	ADJ
ajlm-1597	21	3	considerations	consideration	NOUN
ajlm-1597	21	4	ethical	ethical	ADJ
ajlm-1597	21	5	approval	approval	NOUN
ajlm-1597	21	6	was	be	AUX
ajlm-1597	21	7	obtained	obtain	VERB
ajlm-1597	21	8	from	from	ADP
ajlm-1597	21	9	the	the	DET
ajlm-1597	21	10	university	university	NOUN
ajlm-1597	21	11	of	of	ADP
ajlm-1597	21	12	the	the	DET
ajlm-1597	21	13	witwatersrand	witwatersrand	NOUN
ajlm-1597	21	14	human	human	PROPN
ajlm-1597	21	15	research	research	PROPN
ajlm-1597	21	16	ethics	ethic	NOUN
ajlm-1597	21	17	committee	committee	PROPN
ajlm-1597	21	18	(	(	PUNCT
ajlm-1597	21	19	clearance	clearance	NOUN
ajlm-1597	21	20	certificate	certificate	NOUN
ajlm-1597	21	21	number	number	NOUN
ajlm-1597	21	22	m191048	m191048	PROPN
ajlm-1597	21	23	med	med	ADJ
ajlm-1597	21	24	19	19	NUM
ajlm-1597	21	25	-	-	SYM
ajlm-1597	21	26	10	10	NUM
ajlm-1597	21	27	-	-	PUNCT
ajlm-1597	21	28	043	043	NUM
ajlm-1597	21	29	)	)	PUNCT
ajlm-1597	21	30	.	.	PUNCT
ajlm-1597	22	1	data	datum	NOUN
ajlm-1597	22	2	were	be	AUX
ajlm-1597	22	3	anonymised	anonymise	VERB
ajlm-1597	22	4	before	before	ADP
ajlm-1597	22	5	analysis	analysis	NOUN
ajlm-1597	22	6	to	to	PART
ajlm-1597	22	7	maintain	maintain	VERB
ajlm-1597	22	8	patient	patient	ADJ
ajlm-1597	22	9	confidentiality	confidentiality	NOUN
ajlm-1597	22	10	.	.	PUNCT
ajlm-1597	23	1	patient	patient	ADJ
ajlm-1597	23	2	consent	consent	NOUN
ajlm-1597	23	3	was	be	AUX
ajlm-1597	23	4	not	not	PART
ajlm-1597	23	5	required	require	VERB
ajlm-1597	23	6	.	.	PUNCT
ajlm-1597	24	1	approval	approval	NOUN
ajlm-1597	24	2	to	to	PART
ajlm-1597	24	3	utilise	utilise	VERB
ajlm-1597	24	4	patient	patient	ADJ
ajlm-1597	24	5	data	datum	NOUN
ajlm-1597	24	6	was	be	AUX
ajlm-1597	24	7	obtained	obtain	VERB
ajlm-1597	24	8	from	from	ADP
ajlm-1597	24	9	the	the	DET
ajlm-1597	24	10	chief	chief	ADJ
ajlm-1597	24	11	executive	executive	ADJ
ajlm-1597	24	12	officer	officer	NOUN
ajlm-1597	24	13	of	of	ADP
ajlm-1597	24	14	charlotte	charlotte	PROPN
ajlm-1597	24	15	maxeke	maxeke	PROPN
ajlm-1597	24	16	johannesburg	johannesburg	PROPN
ajlm-1597	24	17	academic	academic	ADJ
ajlm-1597	24	18	hospital	hospital	NOUN
ajlm-1597	24	19	.	.	PUNCT
ajlm-1597	25	1	data	datum	NOUN
ajlm-1597	25	2	collection	collection	NOUN
ajlm-1597	25	3	this	this	PRON
ajlm-1597	25	4	was	be	AUX
ajlm-1597	25	5	a	a	DET
ajlm-1597	25	6	descriptive	descriptive	ADJ
ajlm-1597	25	7	,	,	PUNCT
ajlm-1597	25	8	retrospective	retrospective	ADJ
ajlm-1597	25	9	analysis	analysis	NOUN
ajlm-1597	25	10	of	of	ADP
ajlm-1597	25	11	the	the	DET
ajlm-1597	25	12	a.	a.	NOUN
ajlm-1597	25	13	baumannii	baumannii	PROPN
ajlm-1597	25	14	complex	complex	NOUN
ajlm-1597	25	15	isolated	isolate	VERB
ajlm-1597	25	16	from	from	ADP
ajlm-1597	25	17	charlotte	charlotte	PROPN
ajlm-1597	25	18	maxeke	maxeke	PROPN
ajlm-1597	25	19	johannesburg	johannesburg	PROPN
ajlm-1597	25	20	academic	academic	ADJ
ajlm-1597	25	21	hospital	hospital	NOUN
ajlm-1597	25	22	inpatients	inpatient	NOUN
ajlm-1597	25	23	between	between	ADP
ajlm-1597	25	24	01	01	NUM
ajlm-1597	25	25	january	january	PROPN
ajlm-1597	25	26	2017	2017	NUM
ajlm-1597	25	27	and	and	CCONJ
ajlm-1597	25	28	30	30	NUM
ajlm-1597	25	29	june	june	PROPN
ajlm-1597	25	30	2019	2019	NUM
ajlm-1597	25	31	.	.	PUNCT
ajlm-1597	26	1	the	the	DET
ajlm-1597	26	2	xdr	xdr	PROPN
ajlm-1597	26	3	a.	a.	PROPN
ajlm-1597	26	4	baumannii	baumannii	PROPN
ajlm-1597	26	5	complex	complex	ADJ
ajlm-1597	26	6	isolates	isolate	NOUN
ajlm-1597	26	7	were	be	AUX
ajlm-1597	26	8	resistant	resistant	ADJ
ajlm-1597	26	9	to	to	ADP
ajlm-1597	26	10	one	one	NUM
ajlm-1597	26	11	or	or	CCONJ
ajlm-1597	26	12	more	more	ADJ
ajlm-1597	26	13	agents	agent	NOUN
ajlm-1597	26	14	in	in	ADP
ajlm-1597	26	15	all	all	PRON
ajlm-1597	26	16	but	but	SCONJ
ajlm-1597	26	17	one	one	NUM
ajlm-1597	26	18	or	or	CCONJ
ajlm-1597	26	19	two	two	NUM
ajlm-1597	26	20	categories	category	NOUN
ajlm-1597	26	21	of	of	ADP
ajlm-1597	26	22	antibiotics	antibiotic	NOUN
ajlm-1597	26	23	.	.	PUNCT
ajlm-1597	27	1	microbiological	microbiological	ADJ
ajlm-1597	27	2	data	datum	NOUN
ajlm-1597	27	3	,	,	PUNCT
ajlm-1597	27	4	including	include	VERB
ajlm-1597	27	5	the	the	DET
ajlm-1597	27	6	sample	sample	NOUN
ajlm-1597	27	7	type	type	NOUN
ajlm-1597	27	8	,	,	PUNCT
ajlm-1597	27	9	vitek	vitek	PROPN
ajlm-1597	27	10	®	®	PROPN
ajlm-1597	27	11	2	2	NUM
ajlm-1597	27	12	and	and	CCONJ
ajlm-1597	27	13	mbmd	mbmd	PROPN
ajlm-1597	27	14	colistin	colistin	NOUN
ajlm-1597	27	15	mic	mic	ADJ
ajlm-1597	27	16	results	result	NOUN
ajlm-1597	27	17	,	,	PUNCT
ajlm-1597	27	18	were	be	AUX
ajlm-1597	27	19	extracted	extract	VERB
ajlm-1597	27	20	from	from	ADP
ajlm-1597	27	21	the	the	DET
ajlm-1597	27	22	corporate	corporate	ADJ
ajlm-1597	27	23	data	datum	NOUN
ajlm-1597	27	24	warehouse	warehouse	NOUN
ajlm-1597	27	25	,	,	PUNCT
ajlm-1597	27	26	a	a	DET
ajlm-1597	27	27	division	division	NOUN
ajlm-1597	27	28	of	of	ADP
ajlm-1597	27	29	the	the	DET
ajlm-1597	27	30	national	national	PROPN
ajlm-1597	27	31	health	health	PROPN
ajlm-1597	27	32	laboratory	laboratory	PROPN
ajlm-1597	27	33	service	service	NOUN
ajlm-1597	27	34	(	(	PUNCT
ajlm-1597	27	35	nhls	nhls	PROPN
ajlm-1597	27	36	)	)	PUNCT
ajlm-1597	27	37	.	.	PUNCT
ajlm-1597	28	1	isolate	isolate	VERB
ajlm-1597	28	2	identification	identification	NOUN
ajlm-1597	28	3	and	and	CCONJ
ajlm-1597	28	4	ast	ast	NOUN
ajlm-1597	28	5	microbiology	microbiology	NOUN
ajlm-1597	28	6	services	service	NOUN
ajlm-1597	28	7	within	within	ADP
ajlm-1597	28	8	the	the	DET
ajlm-1597	28	9	hospital	hospital	NOUN
ajlm-1597	28	10	are	be	AUX
ajlm-1597	28	11	provided	provide	VERB
ajlm-1597	28	12	by	by	ADP
ajlm-1597	28	13	the	the	DET
ajlm-1597	28	14	nhls	nhls	NOUN
ajlm-1597	28	15	.	.	PUNCT
ajlm-1597	29	1	the	the	DET
ajlm-1597	29	2	identification	identification	NOUN
ajlm-1597	29	3	of	of	ADP
ajlm-1597	29	4	isolates	isolate	NOUN
ajlm-1597	29	5	within	within	ADP
ajlm-1597	29	6	the	the	DET
ajlm-1597	29	7	institution	institution	NOUN
ajlm-1597	29	8	was	be	AUX
ajlm-1597	29	9	performed	perform	VERB
ajlm-1597	29	10	using	use	VERB
ajlm-1597	29	11	either	either	CCONJ
ajlm-1597	29	12	the	the	DET
ajlm-1597	29	13	vitek	vitek	PROPN
ajlm-1597	29	14	®	®	PROPN
ajlm-1597	29	15	2	2	NUM
ajlm-1597	29	16	(	(	PUNCT
ajlm-1597	29	17	biomerieux	biomerieux	PROPN
ajlm-1597	29	18	inc	inc	PROPN
ajlm-1597	29	19	.	.	PROPN
ajlm-1597	29	20	,	,	PUNCT
ajlm-1597	29	21	marcy	marcy	PROPN
ajlm-1597	29	22	l’étoile	l’étoile	PROPN
ajlm-1597	29	23	,	,	PUNCT
ajlm-1597	29	24	france	france	PROPN
ajlm-1597	29	25	)	)	PUNCT
ajlm-1597	29	26	gram	gram	NOUN
ajlm-1597	29	27	-	-	PUNCT
ajlm-1597	29	28	negative	negative	ADJ
ajlm-1597	29	29	identification	identification	NOUN
ajlm-1597	29	30	(	(	PUNCT
ajlm-1597	29	31	gn	gn	PROPN
ajlm-1597	29	32	i	i	PROPN
ajlm-1597	29	33	d	d	PROPN
ajlm-1597	29	34	)	)	PUNCT
ajlm-1597	29	35	card	card	NOUN
ajlm-1597	29	36	or	or	CCONJ
ajlm-1597	29	37	matrix	matrix	NOUN
ajlm-1597	29	38	-	-	PUNCT
ajlm-1597	29	39	assisted	assist	VERB
ajlm-1597	29	40	laser	laser	NOUN
ajlm-1597	29	41	desorption	desorption	NOUN
ajlm-1597	29	42	ionisation	ionisation	NOUN
ajlm-1597	29	43	-	-	PUNCT
ajlm-1597	29	44	time	time	NOUN
ajlm-1597	29	45	of	of	ADP
ajlm-1597	29	46	flight	flight	NOUN
ajlm-1597	29	47	mass	mass	NOUN
ajlm-1597	29	48	spectrometry	spectrometry	NOUN
ajlm-1597	29	49	.	.	PUNCT
ajlm-1597	30	1	these	these	DET
ajlm-1597	30	2	methods	method	NOUN
ajlm-1597	30	3	are	be	AUX
ajlm-1597	30	4	unable	unable	ADJ
ajlm-1597	30	5	to	to	PART
ajlm-1597	30	6	differentiate	differentiate	VERB
ajlm-1597	30	7	species	specie	NOUN
ajlm-1597	30	8	within	within	ADP
ajlm-1597	30	9	the	the	DET
ajlm-1597	30	10	a.	a.	NOUN
ajlm-1597	30	11	baumannii	baumannii	PROPN
ajlm-1597	30	12	complex	complex	PROPN
ajlm-1597	30	13	.	.	PUNCT
ajlm-1597	31	1	routine	routine	ADJ
ajlm-1597	31	2	ast	ast	NOUN
ajlm-1597	31	3	was	be	AUX
ajlm-1597	31	4	performed	perform	VERB
ajlm-1597	31	5	using	use	VERB
ajlm-1597	31	6	the	the	DET
ajlm-1597	31	7	kirby	kirby	PROPN
ajlm-1597	31	8	-	-	PUNCT
ajlm-1597	31	9	bauer	bauer	PROPN
ajlm-1597	31	10	disc	disc	NOUN
ajlm-1597	31	11	diffusion	diffusion	NOUN
ajlm-1597	31	12	susceptibility	susceptibility	NOUN
ajlm-1597	31	13	method	method	NOUN
ajlm-1597	31	14	or	or	CCONJ
ajlm-1597	31	15	vitek	vitek	PROPN
ajlm-1597	31	16	®	®	PROPN
ajlm-1597	31	17	2	2	NUM
ajlm-1597	31	18	ast	ast	PROPN
ajlm-1597	31	19	-	-	PUNCT
ajlm-1597	31	20	n256	n256	PROPN
ajlm-1597	31	21	card	card	NOUN
ajlm-1597	31	22	.	.	PUNCT
ajlm-1597	32	1	isolates	isolate	NOUN
ajlm-1597	32	2	that	that	PRON
ajlm-1597	32	3	had	have	AUX
ajlm-1597	32	4	ast	ast	VERB
ajlm-1597	32	5	by	by	ADP
ajlm-1597	32	6	the	the	DET
ajlm-1597	32	7	former	former	ADJ
ajlm-1597	32	8	method	method	NOUN
ajlm-1597	32	9	were	be	AUX
ajlm-1597	32	10	excluded	exclude	VERB
ajlm-1597	32	11	from	from	ADP
ajlm-1597	32	12	the	the	DET
ajlm-1597	32	13	study	study	NOUN
ajlm-1597	32	14	.	.	PUNCT
ajlm-1597	33	1	quality	quality	NOUN
ajlm-1597	33	2	control	control	NOUN
ajlm-1597	33	3	strains	strain	NOUN
ajlm-1597	33	4	and	and	CCONJ
ajlm-1597	33	5	pure	pure	ADJ
ajlm-1597	33	6	cultures	culture	NOUN
ajlm-1597	33	7	of	of	ADP
ajlm-1597	33	8	test	test	NOUN
ajlm-1597	33	9	isolates	isolate	NOUN
ajlm-1597	33	10	were	be	AUX
ajlm-1597	33	11	used	use	VERB
ajlm-1597	33	12	for	for	ADP
ajlm-1597	33	13	the	the	DET
ajlm-1597	33	14	vitek	vitek	PROPN
ajlm-1597	33	15	®	®	PROPN
ajlm-1597	33	16	2	2	NUM
ajlm-1597	33	17	ast	ast	NOUN
ajlm-1597	33	18	.	.	PUNCT
ajlm-1597	34	1	isolates	isolate	NOUN
ajlm-1597	34	2	were	be	AUX
ajlm-1597	34	3	further	far	ADV
ajlm-1597	34	4	tested	test	VERB
ajlm-1597	34	5	using	use	VERB
ajlm-1597	34	6	mbmd	mbmd	NOUN
ajlm-1597	34	7	when	when	SCONJ
ajlm-1597	34	8	colistin	colistin	PROPN
ajlm-1597	34	9	therapy	therapy	NOUN
ajlm-1597	34	10	was	be	AUX
ajlm-1597	34	11	considered	consider	VERB
ajlm-1597	34	12	,	,	PUNCT
ajlm-1597	34	13	that	that	ADV
ajlm-1597	34	14	is	is	ADV
ajlm-1597	34	15	,	,	PUNCT
ajlm-1597	34	16	for	for	ADP
ajlm-1597	34	17	clinically	clinically	ADV
ajlm-1597	34	18	significant	significant	ADJ
ajlm-1597	34	19	xdr	xdr	PROPN
ajlm-1597	34	20	a.	a.	NOUN
ajlm-1597	34	21	baumannii	baumannii	PROPN
ajlm-1597	34	22	complex	complex	ADJ
ajlm-1597	34	23	isolates	isolate	NOUN
ajlm-1597	34	24	.	.	PUNCT
ajlm-1597	35	1	manual	manual	PROPN
ajlm-1597	35	2	bmd	bmd	PROPN
ajlm-1597	35	3	was	be	AUX
ajlm-1597	35	4	performed	perform	VERB
ajlm-1597	35	5	by	by	ADP
ajlm-1597	35	6	trained	train	VERB
ajlm-1597	35	7	personnel	personnel	NOUN
ajlm-1597	35	8	with	with	ADP
ajlm-1597	35	9	appropriate	appropriate	ADJ
ajlm-1597	35	10	controls	control	NOUN
ajlm-1597	35	11	according	accord	VERB
ajlm-1597	35	12	to	to	ADP
ajlm-1597	35	13	the	the	DET
ajlm-1597	35	14	iso-20776	iso-20776	ADJ
ajlm-1597	35	15	recommendation	recommendation	NOUN
ajlm-1597	35	16	.	.	PUNCT
ajlm-1597	36	1	isolates	isolate	NOUN
ajlm-1597	36	2	that	that	PRON
ajlm-1597	36	3	were	be	AUX
ajlm-1597	36	4	colistin	colistin	NOUN
ajlm-1597	36	5	-	-	PUNCT
ajlm-1597	36	6	resistant	resistant	ADJ
ajlm-1597	36	7	by	by	ADP
ajlm-1597	36	8	mbmd	mbmd	NOUN
ajlm-1597	36	9	were	be	AUX
ajlm-1597	36	10	then	then	ADV
ajlm-1597	36	11	sent	send	VERB
ajlm-1597	36	12	to	to	ADP
ajlm-1597	36	13	a	a	DET
ajlm-1597	36	14	reference	reference	NOUN
ajlm-1597	36	15	laboratory	laboratory	NOUN
ajlm-1597	36	16	for	for	ADP
ajlm-1597	36	17	mcr	mcr	PROPN
ajlm-1597	36	18	1	1	NUM
ajlm-1597	36	19	-	-	SYM
ajlm-1597	36	20	5	5	NUM
ajlm-1597	36	21	testing	testing	NOUN
ajlm-1597	36	22	(	(	PUNCT
ajlm-1597	36	23	data	datum	NOUN
ajlm-1597	36	24	not	not	PART
ajlm-1597	36	25	shown	show	VERB
ajlm-1597	36	26	)	)	PUNCT
ajlm-1597	36	27	.	.	PUNCT
ajlm-1597	37	1	data	datum	NOUN
ajlm-1597	37	2	analysis	analysis	NOUN
ajlm-1597	37	3	all	all	DET
ajlm-1597	37	4	xdr	xdr	PROPN
ajlm-1597	37	5	a.	a.	NOUN
ajlm-1597	37	6	baumannii	baumannii	PROPN
ajlm-1597	37	7	complex	complex	ADJ
ajlm-1597	37	8	isolates	isolate	NOUN
ajlm-1597	37	9	cultured	cultured	ADJ
ajlm-1597	37	10	between	between	ADP
ajlm-1597	37	11	01	01	NUM
ajlm-1597	37	12	january	january	PROPN
ajlm-1597	37	13	2017	2017	NUM
ajlm-1597	37	14	and	and	CCONJ
ajlm-1597	37	15	30	30	NUM
ajlm-1597	37	16	june	june	PROPN
ajlm-1597	37	17	2019	2019	NUM
ajlm-1597	37	18	were	be	AUX
ajlm-1597	37	19	analysed	analyse	VERB
ajlm-1597	37	20	.	.	PUNCT
ajlm-1597	38	1	no	no	DET
ajlm-1597	38	2	patient	patient	ADJ
ajlm-1597	38	3	admission	admission	NOUN
ajlm-1597	38	4	data	datum	NOUN
ajlm-1597	38	5	was	be	AUX
ajlm-1597	38	6	available	available	ADJ
ajlm-1597	38	7	to	to	PART
ajlm-1597	38	8	discriminate	discriminate	VERB
ajlm-1597	38	9	between	between	ADP
ajlm-1597	38	10	community	community	NOUN
ajlm-1597	38	11	-	-	PUNCT
ajlm-1597	38	12	acquired	acquire	VERB
ajlm-1597	38	13	and	and	CCONJ
ajlm-1597	38	14	hospital	hospital	NOUN
ajlm-1597	38	15	-	-	PUNCT
ajlm-1597	38	16	acquired	acquire	VERB
ajlm-1597	38	17	infections	infection	NOUN
ajlm-1597	38	18	.	.	PUNCT
ajlm-1597	39	1	isolates	isolate	NOUN
ajlm-1597	39	2	that	that	PRON
ajlm-1597	39	3	were	be	AUX
ajlm-1597	39	4	obtained	obtain	VERB
ajlm-1597	39	5	from	from	ADP
ajlm-1597	39	6	outpatient	outpatient	NOUN
ajlm-1597	39	7	departments	department	NOUN
ajlm-1597	39	8	or	or	CCONJ
ajlm-1597	39	9	without	without	ADP
ajlm-1597	39	10	the	the	DET
ajlm-1597	39	11	ward	ward	NOUN
ajlm-1597	39	12	specified	specify	VERB
ajlm-1597	39	13	were	be	AUX
ajlm-1597	39	14	excluded	exclude	VERB
ajlm-1597	39	15	.	.	PUNCT
ajlm-1597	40	1	duplicate	duplicate	VERB
ajlm-1597	40	2	patient	patient	ADJ
ajlm-1597	40	3	samples	sample	NOUN
ajlm-1597	40	4	,	,	PUNCT
ajlm-1597	40	5	such	such	ADJ
ajlm-1597	40	6	as	as	ADP
ajlm-1597	40	7	blood	blood	NOUN
ajlm-1597	40	8	cultures	culture	NOUN
ajlm-1597	40	9	collected	collect	VERB
ajlm-1597	40	10	within	within	ADP
ajlm-1597	40	11	two	two	NUM
ajlm-1597	40	12	weeks	week	NOUN
ajlm-1597	40	13	and	and	CCONJ
ajlm-1597	40	14	other	other	ADJ
ajlm-1597	40	15	sample	sample	NOUN
ajlm-1597	40	16	types	type	NOUN
ajlm-1597	40	17	collected	collect	VERB
ajlm-1597	40	18	within	within	ADP
ajlm-1597	40	19	one	one	NUM
ajlm-1597	40	20	month	month	NOUN
ajlm-1597	40	21	of	of	ADP
ajlm-1597	40	22	the	the	DET
ajlm-1597	40	23	initial	initial	ADJ
ajlm-1597	40	24	sample	sample	NOUN
ajlm-1597	40	25	,	,	PUNCT
ajlm-1597	40	26	were	be	AUX
ajlm-1597	40	27	excluded	exclude	VERB
ajlm-1597	40	28	.	.	PUNCT
ajlm-1597	41	1	intravenous	intravenous	ADJ
ajlm-1597	41	2	central	central	ADJ
ajlm-1597	41	3	venous	venous	ADJ
ajlm-1597	41	4	catheter	catheter	NOUN
ajlm-1597	41	5	tips	tip	NOUN
ajlm-1597	41	6	were	be	AUX
ajlm-1597	41	7	not	not	PART
ajlm-1597	41	8	included	include	VERB
ajlm-1597	41	9	as	as	SCONJ
ajlm-1597	41	10	they	they	PRON
ajlm-1597	41	11	were	be	AUX
ajlm-1597	41	12	processed	process	VERB
ajlm-1597	41	13	in	in	ADP
ajlm-1597	41	14	a	a	DET
ajlm-1597	41	15	separate	separate	ADJ
ajlm-1597	41	16	laboratory	laboratory	NOUN
ajlm-1597	41	17	using	use	VERB
ajlm-1597	41	18	a	a	DET
ajlm-1597	41	19	different	different	ADJ
ajlm-1597	41	20	automated	automate	VERB
ajlm-1597	41	21	ast	ast	NOUN
ajlm-1597	41	22	platform	platform	NOUN
ajlm-1597	41	23	.	.	PUNCT
ajlm-1597	42	1	only	only	ADV
ajlm-1597	42	2	isolates	isolate	NOUN
ajlm-1597	42	3	with	with	ADP
ajlm-1597	42	4	both	both	DET
ajlm-1597	42	5	vitek	vitek	PROPN
ajlm-1597	42	6	®	®	PROPN
ajlm-1597	42	7	2	2	NUM
ajlm-1597	42	8	and	and	CCONJ
ajlm-1597	42	9	mbmd	mbmd	PROPN
ajlm-1597	42	10	colistin	colistin	PROPN
ajlm-1597	42	11	susceptibility	susceptibility	NOUN
ajlm-1597	42	12	results	result	NOUN
ajlm-1597	42	13	were	be	AUX
ajlm-1597	42	14	included	include	VERB
ajlm-1597	42	15	.	.	PUNCT
ajlm-1597	43	1	the	the	DET
ajlm-1597	43	2	performance	performance	NOUN
ajlm-1597	43	3	of	of	ADP
ajlm-1597	43	4	vitek	vitek	PROPN
ajlm-1597	43	5	®	®	PROPN
ajlm-1597	43	6	2	2	NUM
ajlm-1597	43	7	colistin	colistin	NOUN
ajlm-1597	43	8	susceptibility	susceptibility	NOUN
ajlm-1597	43	9	testing	testing	NOUN
ajlm-1597	43	10	was	be	AUX
ajlm-1597	43	11	determined	determine	VERB
ajlm-1597	43	12	by	by	ADP
ajlm-1597	43	13	evaluating	evaluate	VERB
ajlm-1597	43	14	the	the	DET
ajlm-1597	43	15	categorical	categorical	ADJ
ajlm-1597	43	16	and	and	CCONJ
ajlm-1597	43	17	essential	essential	ADJ
ajlm-1597	43	18	agreements	agreement	NOUN
ajlm-1597	43	19	and	and	CCONJ
ajlm-1597	43	20	the	the	DET
ajlm-1597	43	21	major	major	ADJ
ajlm-1597	43	22	and	and	CCONJ
ajlm-1597	43	23	vme	vme	NUM
ajlm-1597	43	24	rates	rate	NOUN
ajlm-1597	43	25	in	in	ADP
ajlm-1597	43	26	comparison	comparison	NOUN
ajlm-1597	43	27	to	to	ADP
ajlm-1597	43	28	the	the	DET
ajlm-1597	43	29	mbmd	mbmd	PROPN
ajlm-1597	43	30	colistin	colistin	PROPN
ajlm-1597	43	31	susceptibility	susceptibility	NOUN
ajlm-1597	43	32	testing	testing	NOUN
ajlm-1597	43	33	method	method	NOUN
ajlm-1597	43	34	,	,	PUNCT
ajlm-1597	43	35	according	accord	VERB
ajlm-1597	43	36	to	to	ADP
ajlm-1597	43	37	the	the	DET
ajlm-1597	43	38	food	food	NOUN
ajlm-1597	43	39	and	and	CCONJ
ajlm-1597	43	40	drug	drug	PROPN
ajlm-1597	43	41	administration	administration	PROPN
ajlm-1597	43	42	(	(	PUNCT
ajlm-1597	43	43	fda	fda	PROPN
ajlm-1597	43	44	)	)	PUNCT
ajlm-1597	43	45	recommendations.11	recommendations.11	VERB
ajlm-1597	43	46	microsoft	microsoft	PROPN
ajlm-1597	43	47	®	®	NOUN
ajlm-1597	43	48	excel	excel	VERB
ajlm-1597	43	49	2016	2016	NUM
ajlm-1597	43	50	(	(	PUNCT
ajlm-1597	43	51	microsoft	microsoft	PROPN
ajlm-1597	43	52	corporation	corporation	PROPN
ajlm-1597	43	53	,	,	PUNCT
ajlm-1597	43	54	redmond	redmond	PROPN
ajlm-1597	43	55	,	,	PUNCT
ajlm-1597	43	56	washington	washington	PROPN
ajlm-1597	43	57	,	,	PUNCT
ajlm-1597	43	58	united	united	PROPN
ajlm-1597	43	59	states	states	PROPN
ajlm-1597	43	60	)	)	PUNCT
ajlm-1597	43	61	was	be	AUX
ajlm-1597	43	62	used	use	VERB
ajlm-1597	43	63	for	for	ADP
ajlm-1597	43	64	data	datum	NOUN
ajlm-1597	43	65	analysis	analysis	NOUN
ajlm-1597	43	66	.	.	PUNCT
ajlm-1597	44	1	the	the	DET
ajlm-1597	44	2	following	follow	VERB
ajlm-1597	44	3	equations	equation	NOUN
ajlm-1597	44	4	were	be	AUX
ajlm-1597	44	5	employed	employ	VERB
ajlm-1597	44	6	to	to	PART
ajlm-1597	44	7	assess	assess	VERB
ajlm-1597	44	8	agreement	agreement	NOUN
ajlm-1597	44	9	and	and	CCONJ
ajlm-1597	44	10	error	error	NOUN
ajlm-1597	44	11	rates	rate	NOUN
ajlm-1597	44	12	:	:	PUNCT
ajlm-1597	44	13	categorical	categorical	ADJ
ajlm-1597	44	14	agreement	agreement	NOUN
ajlm-1597	44	15	=	=	PUNCT
ajlm-1597	44	16	(	(	PUNCT
ajlm-1597	44	17	number	number	NOUN
ajlm-1597	44	18	of	of	ADP
ajlm-1597	44	19	isolates	isolate	NOUN
ajlm-1597	44	20	correctly	correctly	ADV
ajlm-1597	44	21	classified	classify	VERB
ajlm-1597	44	22	by	by	ADP
ajlm-1597	44	23	vitek	vitek	PROPN
ajlm-1597	44	24	®	®	PROPN
ajlm-1597	44	25	2	2	NUM
ajlm-1597	44	26	as	as	ADP
ajlm-1597	44	27	either	either	CCONJ
ajlm-1597	44	28	colistin	colistin	NOUN
ajlm-1597	44	29	susceptible	susceptible	ADJ
ajlm-1597	44	30	or	or	CCONJ
ajlm-1597	44	31	resistant	resistant	ADJ
ajlm-1597	44	32	in	in	ADP
ajlm-1597	44	33	comparison	comparison	NOUN
ajlm-1597	44	34	to	to	ADP
ajlm-1597	44	35	mbmd	mbmd	PROPN
ajlm-1597	44	36	÷	÷	PUNCT
ajlm-1597	44	37	total	total	ADJ
ajlm-1597	44	38	number	number	NOUN
ajlm-1597	44	39	of	of	ADP
ajlm-1597	44	40	isolates	isolate	NOUN
ajlm-1597	44	41	tested	test	VERB
ajlm-1597	44	42	)	)	PUNCT
ajlm-1597	45	1	×	×	PROPN
ajlm-1597	46	1	100	100	NUM
ajlm-1597	46	2	    	    	SPACE
ajlm-1597	47	1	[	[	X
ajlm-1597	47	2	eqn	eqn	NOUN
ajlm-1597	47	3	1	1	NUM
ajlm-1597	47	4	]	]	X
ajlm-1597	47	5	essential	essential	ADJ
ajlm-1597	47	6	agreement	agreement	NOUN
ajlm-1597	47	7	=	=	PUNCT
ajlm-1597	47	8	(	(	PUNCT
ajlm-1597	47	9	number	number	NOUN
ajlm-1597	47	10	of	of	ADP
ajlm-1597	47	11	isolates	isolate	NOUN
ajlm-1597	47	12	within	within	ADP
ajlm-1597	47	13	one	one	NUM
ajlm-1597	47	14	doubling	double	VERB
ajlm-1597	47	15	dilutions	dilution	NOUN
ajlm-1597	47	16	of	of	ADP
ajlm-1597	47	17	the	the	DET
ajlm-1597	47	18	mbmd	mbmd	ADJ
ajlm-1597	47	19	mic	mic	NOUN
ajlm-1597	47	20	on	on	ADP
ajlm-1597	47	21	vitek	vitek	PROPN
ajlm-1597	47	22	®	®	PROPN
ajlm-1597	47	23	2	2	NUM
ajlm-1597	47	24	÷	÷	NUM
ajlm-1597	47	25	total	total	ADJ
ajlm-1597	47	26	number	number	NOUN
ajlm-1597	47	27	of	of	ADP
ajlm-1597	47	28	isolates	isolate	NOUN
ajlm-1597	47	29	tested	test	VERB
ajlm-1597	47	30	)	)	PUNCT
ajlm-1597	47	31	×	×	PROPN
ajlm-1597	47	32	100	100	NUM
ajlm-1597	47	33	    	    	SPACE
ajlm-1597	48	1	[	[	X
ajlm-1597	48	2	eqn	eqn	NOUN
ajlm-1597	48	3	2	2	NUM
ajlm-1597	48	4	]	]	X
ajlm-1597	48	5	major	major	ADJ
ajlm-1597	48	6	error	error	NOUN
ajlm-1597	48	7	rate	rate	NOUN
ajlm-1597	48	8	=	=	PUNCT
ajlm-1597	48	9	(	(	PUNCT
ajlm-1597	48	10	number	number	NOUN
ajlm-1597	48	11	of	of	ADP
ajlm-1597	48	12	falsely	falsely	ADV
ajlm-1597	48	13	resistant	resistant	ADJ
ajlm-1597	48	14	isolates	isolate	NOUN
ajlm-1597	48	15	on	on	ADP
ajlm-1597	48	16	vitek	vitek	PROPN
ajlm-1597	48	17	®	®	PROPN
ajlm-1597	48	18	2	2	NUM
ajlm-1597	48	19	÷	÷	NUM
ajlm-1597	48	20	number	number	NOUN
ajlm-1597	48	21	of	of	ADP
ajlm-1597	48	22	susceptible	susceptible	ADJ
ajlm-1597	48	23	isolates	isolate	NOUN
ajlm-1597	48	24	by	by	ADP
ajlm-1597	48	25	mbmd	mbmd	NOUN
ajlm-1597	48	26	)	)	PUNCT
ajlm-1597	48	27	×	×	NOUN
ajlm-1597	48	28	100	100	NUM
ajlm-1597	48	29	    	    	SPACE
ajlm-1597	49	1	[	[	X
ajlm-1597	49	2	eqn	eqn	NOUN
ajlm-1597	49	3	3	3	NUM
ajlm-1597	49	4	]	]	X
ajlm-1597	49	5	very	very	ADV
ajlm-1597	49	6	major	major	ADJ
ajlm-1597	49	7	error	error	NOUN
ajlm-1597	49	8	rate	rate	NOUN
ajlm-1597	49	9	=	=	PUNCT
ajlm-1597	49	10	(	(	PUNCT
ajlm-1597	49	11	number	number	NOUN
ajlm-1597	49	12	of	of	ADP
ajlm-1597	49	13	falsely	falsely	ADV
ajlm-1597	49	14	susceptible	susceptible	ADJ
ajlm-1597	49	15	isolates	isolate	NOUN
ajlm-1597	49	16	by	by	ADP
ajlm-1597	49	17	vitek	vitek	PROPN
ajlm-1597	49	18	®	®	PROPN
ajlm-1597	49	19	2	2	NUM
ajlm-1597	49	20	÷	÷	NUM
ajlm-1597	49	21	number	number	NOUN
ajlm-1597	49	22	of	of	ADP
ajlm-1597	49	23	resistant	resistant	ADJ
ajlm-1597	49	24	isolates	isolate	NOUN
ajlm-1597	49	25	by	by	ADP
ajlm-1597	49	26	mbmd	mbmd	NOUN
ajlm-1597	49	27	)	)	PUNCT
ajlm-1597	49	28	×	×	NOUN
ajlm-1597	49	29	100	100	NUM
ajlm-1597	49	30	    	    	SPACE
ajlm-1597	50	1	[	[	X
ajlm-1597	50	2	eqn	eqn	NOUN
ajlm-1597	50	3	4	4	NUM
ajlm-1597	50	4	]	]	PUNCT
ajlm-1597	50	5	results	result	VERB
ajlm-1597	50	6	data	datum	NOUN
ajlm-1597	50	7	for	for	ADP
ajlm-1597	50	8	523	523	NUM
ajlm-1597	50	9	isolates	isolate	NOUN
ajlm-1597	50	10	were	be	AUX
ajlm-1597	50	11	obtained	obtain	VERB
ajlm-1597	50	12	from	from	ADP
ajlm-1597	50	13	all	all	DET
ajlm-1597	50	14	specimen	speciman	NOUN
ajlm-1597	50	15	types	type	NOUN
ajlm-1597	50	16	that	that	PRON
ajlm-1597	50	17	harboured	harbour	VERB
ajlm-1597	50	18	xdr	xdr	PROPN
ajlm-1597	50	19	a.	a.	NOUN
ajlm-1597	50	20	baumannii	baumannii	PROPN
ajlm-1597	50	21	complex	complex	NOUN
ajlm-1597	50	22	and	and	CCONJ
ajlm-1597	50	23	were	be	AUX
ajlm-1597	50	24	submitted	submit	VERB
ajlm-1597	50	25	for	for	ADP
ajlm-1597	50	26	colistin	colistin	NOUN
ajlm-1597	50	27	mbmd	mbmd	NOUN
ajlm-1597	50	28	.	.	PUNCT
ajlm-1597	51	1	after	after	ADP
ajlm-1597	51	2	appropriate	appropriate	ADJ
ajlm-1597	51	3	exclusions	exclusion	NOUN
ajlm-1597	51	4	,	,	PUNCT
ajlm-1597	51	5	337	337	NUM
ajlm-1597	51	6	(	(	PUNCT
ajlm-1597	51	7	64	64	NUM
ajlm-1597	51	8	%	%	NOUN
ajlm-1597	51	9	)	)	PUNCT
ajlm-1597	51	10	isolates	isolate	NOUN
ajlm-1597	51	11	had	have	VERB
ajlm-1597	51	12	both	both	DET
ajlm-1597	51	13	vitek	vitek	PROPN
ajlm-1597	51	14	®	®	PROPN
ajlm-1597	51	15	2	2	NUM
ajlm-1597	51	16	and	and	CCONJ
ajlm-1597	51	17	mbmd	mbmd	ADJ
ajlm-1597	51	18	mic	mic	ADJ
ajlm-1597	51	19	results	result	NOUN
ajlm-1597	51	20	(	(	PUNCT
ajlm-1597	51	21	figure	figure	NOUN
ajlm-1597	51	22	1	1	NUM
ajlm-1597	51	23	)	)	PUNCT
ajlm-1597	51	24	.	.	PUNCT
ajlm-1597	52	1	figure	figure	NOUN
ajlm-1597	52	2	1	1	NUM
ajlm-1597	52	3	:	:	PUNCT
ajlm-1597	52	4	isolate	isolate	VERB
ajlm-1597	52	5	selection	selection	NOUN
ajlm-1597	52	6	and	and	CCONJ
ajlm-1597	52	7	inclusion	inclusion	NOUN
ajlm-1597	52	8	for	for	ADP
ajlm-1597	52	9	vitek	vitek	PROPN
ajlm-1597	52	10	®	®	PROPN
ajlm-1597	52	11	2	2	NUM
ajlm-1597	52	12	colistin	colistin	NOUN
ajlm-1597	52	13	susceptibility	susceptibility	NOUN
ajlm-1597	52	14	assessment	assessment	NOUN
ajlm-1597	52	15	.	.	PUNCT
ajlm-1597	53	1	of	of	ADP
ajlm-1597	53	2	the	the	DET
ajlm-1597	53	3	337	337	NUM
ajlm-1597	53	4	isolates	isolate	NOUN
ajlm-1597	53	5	with	with	ADP
ajlm-1597	53	6	both	both	DET
ajlm-1597	53	7	vitek	vitek	PROPN
ajlm-1597	53	8	®	®	PROPN
ajlm-1597	53	9	2	2	NUM
ajlm-1597	53	10	and	and	CCONJ
ajlm-1597	53	11	mbmd	mbmd	PROPN
ajlm-1597	53	12	colistin	colistin	PROPN
ajlm-1597	53	13	susceptibility	susceptibility	NOUN
ajlm-1597	53	14	results	result	NOUN
ajlm-1597	53	15	,	,	PUNCT
ajlm-1597	53	16	20	20	NUM
ajlm-1597	53	17	(	(	PUNCT
ajlm-1597	53	18	6	6	NUM
ajlm-1597	53	19	%	%	NOUN
ajlm-1597	53	20	)	)	PUNCT
ajlm-1597	53	21	were	be	AUX
ajlm-1597	53	22	resistant	resistant	ADJ
ajlm-1597	53	23	to	to	PART
ajlm-1597	53	24	colistin	colistin	VERB
ajlm-1597	53	25	by	by	ADP
ajlm-1597	53	26	mbmd	mbmd	NOUN
ajlm-1597	53	27	.	.	PUNCT
ajlm-1597	54	1	the	the	DET
ajlm-1597	54	2	highest	high	ADJ
ajlm-1597	54	3	proportion	proportion	NOUN
ajlm-1597	54	4	of	of	ADP
ajlm-1597	54	5	colistin	colistin	NOUN
ajlm-1597	54	6	-	-	PUNCT
ajlm-1597	54	7	resistant	resistant	ADJ
ajlm-1597	54	8	acinetobacter	acinetobacter	NOUN
ajlm-1597	54	9	was	be	AUX
ajlm-1597	54	10	isolated	isolate	VERB
ajlm-1597	54	11	from	from	ADP
ajlm-1597	54	12	tracheal	tracheal	NOUN
ajlm-1597	54	13	aspirates	aspirate	NOUN
ajlm-1597	54	14	and	and	CCONJ
ajlm-1597	54	15	swabs	swab	NOUN
ajlm-1597	54	16	(	(	PUNCT
ajlm-1597	54	17	figure	figure	NOUN
ajlm-1597	54	18	2	2	NUM
ajlm-1597	54	19	)	)	PUNCT
ajlm-1597	54	20	.	.	PUNCT
ajlm-1597	55	1	figure	figure	VERB
ajlm-1597	55	2	2	2	NUM
ajlm-1597	55	3	:	:	PUNCT
ajlm-1597	55	4	distribution	distribution	NOUN
ajlm-1597	55	5	of	of	ADP
ajlm-1597	55	6	colistin	colistin	NOUN
ajlm-1597	55	7	-	-	PUNCT
ajlm-1597	55	8	resistant	resistant	ADJ
ajlm-1597	55	9	and	and	CCONJ
ajlm-1597	55	10	susceptible	susceptible	ADJ
ajlm-1597	55	11	xdr	xdr	PROPN
ajlm-1597	55	12	a.	a.	NOUN
ajlm-1597	55	13	baumannii	baumannii	PROPN
ajlm-1597	55	14	complex	complex	ADJ
ajlm-1597	55	15	isolates	isolate	NOUN
ajlm-1597	55	16	by	by	ADP
ajlm-1597	55	17	sample	sample	NOUN
ajlm-1597	55	18	type	type	NOUN
ajlm-1597	55	19	(	(	PUNCT
ajlm-1597	55	20	n	n	NOUN
ajlm-1597	55	21	=	=	SYM
ajlm-1597	55	22	337	337	NUM
ajlm-1597	55	23	)	)	PUNCT
ajlm-1597	55	24	.	.	PUNCT
ajlm-1597	56	1	vitek	vitek	PROPN
ajlm-1597	56	2	®	®	PROPN
ajlm-1597	56	3	2	2	NUM
ajlm-1597	56	4	was	be	AUX
ajlm-1597	56	5	found	find	VERB
ajlm-1597	56	6	to	to	PART
ajlm-1597	56	7	have	have	VERB
ajlm-1597	56	8	a	a	DET
ajlm-1597	56	9	categorical	categorical	ADJ
ajlm-1597	56	10	agreement	agreement	NOUN
ajlm-1597	56	11	of	of	ADP
ajlm-1597	56	12	89	89	NUM
ajlm-1597	56	13	%	%	NOUN
ajlm-1597	56	14	(	(	PUNCT
ajlm-1597	56	15	300/337	300/337	NUM
ajlm-1597	56	16	)	)	PUNCT
ajlm-1597	56	17	and	and	CCONJ
ajlm-1597	56	18	an	an	DET
ajlm-1597	56	19	essential	essential	ADJ
ajlm-1597	56	20	agreement	agreement	NOUN
ajlm-1597	56	21	of	of	ADP
ajlm-1597	56	22	56	56	NUM
ajlm-1597	56	23	%	%	NOUN
ajlm-1597	56	24	(	(	PUNCT
ajlm-1597	56	25	190/337	190/337	NUM
ajlm-1597	56	26	)	)	PUNCT
ajlm-1597	56	27	with	with	ADP
ajlm-1597	56	28	mbmd	mbmd	NOUN
ajlm-1597	56	29	.	.	PUNCT
ajlm-1597	57	1	the	the	DET
ajlm-1597	57	2	vme	vme	PROPN
ajlm-1597	57	3	rate	rate	NOUN
ajlm-1597	57	4	was	be	AUX
ajlm-1597	57	5	55	55	NUM
ajlm-1597	57	6	%	%	NOUN
ajlm-1597	57	7	(	(	PUNCT
ajlm-1597	57	8	11/20	11/20	NUM
ajlm-1597	57	9	)	)	PUNCT
ajlm-1597	57	10	and	and	CCONJ
ajlm-1597	57	11	the	the	DET
ajlm-1597	57	12	major	major	ADJ
ajlm-1597	57	13	error	error	NOUN
ajlm-1597	57	14	rate	rate	NOUN
ajlm-1597	57	15	was	be	AUX
ajlm-1597	57	16	8	8	NUM
ajlm-1597	57	17	%	%	NOUN
ajlm-1597	57	18	(	(	PUNCT
ajlm-1597	57	19	26/317	26/317	NUM
ajlm-1597	57	20	)	)	PUNCT
ajlm-1597	57	21	(	(	PUNCT
ajlm-1597	57	22	figure	figure	NOUN
ajlm-1597	57	23	3	3	NUM
ajlm-1597	57	24	)	)	PUNCT
ajlm-1597	57	25	.	.	PUNCT
ajlm-1597	58	1	figure	figure	VERB
ajlm-1597	58	2	3	3	NUM
ajlm-1597	58	3	:	:	PUNCT
ajlm-1597	58	4	colistin	colistin	VERB
ajlm-1597	58	5	minimum	minimum	NOUN
ajlm-1597	58	6	inhibitory	inhibitory	ADJ
ajlm-1597	58	7	concentration	concentration	NOUN
ajlm-1597	58	8	(	(	PUNCT
ajlm-1597	58	9	µg	µg	NOUN
ajlm-1597	58	10	/	/	SYM
ajlm-1597	58	11	ml	ml	NOUN
ajlm-1597	58	12	)	)	PUNCT
ajlm-1597	58	13	results	result	NOUN
ajlm-1597	58	14	for	for	ADP
ajlm-1597	58	15	xdr	xdr	PROPN
ajlm-1597	58	16	a.	a.	PROPN
ajlm-1597	58	17	baumannii	baumannii	PROPN
ajlm-1597	58	18	complex	complex	ADJ
ajlm-1597	58	19	isolates	isolate	NOUN
ajlm-1597	58	20	by	by	ADP
ajlm-1597	58	21	both	both	DET
ajlm-1597	58	22	vitek	vitek	PROPN
ajlm-1597	58	23	®	®	PROPN
ajlm-1597	58	24	2	2	NUM
ajlm-1597	58	25	and	and	CCONJ
ajlm-1597	58	26	manual	manual	ADJ
ajlm-1597	58	27	broth	broth	ADJ
ajlm-1597	58	28	micro	micro	NOUN
ajlm-1597	58	29	-	-	NOUN
ajlm-1597	58	30	dilution	dilution	NOUN
ajlm-1597	58	31	.	.	PUNCT
ajlm-1597	59	1	discussion	discussion	NOUN
ajlm-1597	59	2	colistin	colistin	VERB
ajlm-1597	59	3	susceptibility	susceptibility	NOUN
ajlm-1597	59	4	testing	testing	NOUN
ajlm-1597	59	5	by	by	ADP
ajlm-1597	59	6	mbmd	mbmd	NOUN
ajlm-1597	59	7	according	accord	VERB
ajlm-1597	59	8	to	to	ADP
ajlm-1597	59	9	iso-20776	iso-20776	NOUN
ajlm-1597	59	10	is	be	AUX
ajlm-1597	59	11	difficult	difficult	ADJ
ajlm-1597	59	12	to	to	PART
ajlm-1597	59	13	implement	implement	VERB
ajlm-1597	59	14	in	in	ADP
ajlm-1597	59	15	routine	routine	ADJ
ajlm-1597	59	16	microbiology	microbiology	NOUN
ajlm-1597	59	17	laboratories	laboratory	NOUN
ajlm-1597	59	18	.	.	PUNCT
ajlm-1597	60	1	due	due	ADP
ajlm-1597	60	2	to	to	ADP
ajlm-1597	60	3	financial	financial	ADJ
ajlm-1597	60	4	constraints	constraint	NOUN
ajlm-1597	60	5	and	and	CCONJ
ajlm-1597	60	6	the	the	DET
ajlm-1597	60	7	technical	technical	ADJ
ajlm-1597	60	8	competencies	competency	NOUN
ajlm-1597	60	9	required	require	VERB
ajlm-1597	60	10	,	,	PUNCT
ajlm-1597	60	11	only	only	ADV
ajlm-1597	60	12	one	one	NUM
ajlm-1597	60	13	nhls	nhls	ADJ
ajlm-1597	60	14	laboratory	laboratory	NOUN
ajlm-1597	60	15	can	can	AUX
ajlm-1597	60	16	offer	offer	VERB
ajlm-1597	60	17	mbmd	mbmd	NOUN
ajlm-1597	60	18	in	in	ADP
ajlm-1597	60	19	south	south	PROPN
ajlm-1597	60	20	africa	africa	PROPN
ajlm-1597	60	21	.	.	PUNCT
ajlm-1597	61	1	this	this	PRON
ajlm-1597	61	2	is	be	AUX
ajlm-1597	61	3	likely	likely	ADJ
ajlm-1597	61	4	to	to	PART
ajlm-1597	61	5	impair	impair	VERB
ajlm-1597	61	6	patient	patient	ADJ
ajlm-1597	61	7	care	care	NOUN
ajlm-1597	61	8	due	due	ADP
ajlm-1597	61	9	to	to	ADP
ajlm-1597	61	10	delays	delay	NOUN
ajlm-1597	61	11	in	in	ADP
ajlm-1597	61	12	turnaround	turnaround	NOUN
ajlm-1597	61	13	times	time	NOUN
ajlm-1597	61	14	of	of	ADP
ajlm-1597	61	15	results	result	NOUN
ajlm-1597	61	16	.	.	PUNCT
ajlm-1597	62	1	in	in	ADP
ajlm-1597	62	2	contrast	contrast	NOUN
ajlm-1597	62	3	,	,	PUNCT
ajlm-1597	62	4	vitek	vitek	PROPN
ajlm-1597	62	5	®	®	PROPN
ajlm-1597	62	6	2	2	NUM
ajlm-1597	62	7	is	be	AUX
ajlm-1597	62	8	available	available	ADJ
ajlm-1597	62	9	in	in	ADP
ajlm-1597	62	10	most	most	ADJ
ajlm-1597	62	11	nhls	nhls	ADJ
ajlm-1597	62	12	microbiology	microbiology	NOUN
ajlm-1597	62	13	laboratories	laboratory	NOUN
ajlm-1597	62	14	and	and	CCONJ
ajlm-1597	62	15	serves	serve	VERB
ajlm-1597	62	16	as	as	ADP
ajlm-1597	62	17	an	an	DET
ajlm-1597	62	18	alternative	alternative	NOUN
ajlm-1597	62	19	.	.	PUNCT
ajlm-1597	63	1	however	however	ADV
ajlm-1597	63	2	,	,	PUNCT
ajlm-1597	63	3	our	our	PRON
ajlm-1597	63	4	study	study	NOUN
ajlm-1597	63	5	demonstrates	demonstrate	VERB
ajlm-1597	63	6	unacceptable	unacceptable	ADJ
ajlm-1597	63	7	performance	performance	NOUN
ajlm-1597	63	8	,	,	PUNCT
ajlm-1597	63	9	with	with	ADP
ajlm-1597	63	10	11	11	NUM
ajlm-1597	63	11	of	of	ADP
ajlm-1597	63	12	20	20	NUM
ajlm-1597	63	13	(	(	PUNCT
ajlm-1597	63	14	55	55	NUM
ajlm-1597	63	15	%	%	NOUN
ajlm-1597	63	16	)	)	PUNCT
ajlm-1597	63	17	colistin	colistin	NOUN
ajlm-1597	63	18	-	-	PUNCT
ajlm-1597	63	19	resistant	resistant	ADJ
ajlm-1597	63	20	isolates	isolate	NOUN
ajlm-1597	63	21	being	be	AUX
ajlm-1597	63	22	falsely	falsely	ADV
ajlm-1597	63	23	susceptible	susceptible	ADJ
ajlm-1597	63	24	by	by	ADP
ajlm-1597	63	25	vitek	vitek	PROPN
ajlm-1597	63	26	®	®	PROPN
ajlm-1597	63	27	2	2	NUM
ajlm-1597	63	28	.	.	PUNCT
ajlm-1597	64	1	the	the	DET
ajlm-1597	64	2	vitek	vitek	PROPN
ajlm-1597	64	3	®	®	PROPN
ajlm-1597	64	4	2	2	NUM
ajlm-1597	64	5	also	also	ADV
ajlm-1597	64	6	falsely	falsely	ADV
ajlm-1597	64	7	reported	report	VERB
ajlm-1597	64	8	some	some	DET
ajlm-1597	64	9	isolates	isolate	NOUN
ajlm-1597	64	10	with	with	ADP
ajlm-1597	64	11	mbmd	mbmd	PROPN
ajlm-1597	64	12	colistin	colistin	PROPN
ajlm-1597	64	13	mic	mic	NOUN
ajlm-1597	64	14	of	of	ADP
ajlm-1597	64	15	>	>	X
ajlm-1597	64	16	64	64	NUM
ajlm-1597	64	17	µg	µg	NOUN
ajlm-1597	64	18	/	/	SYM
ajlm-1597	64	19	ml	ml	NOUN
ajlm-1597	64	20	as	as	ADV
ajlm-1597	64	21	susceptible	susceptible	ADJ
ajlm-1597	64	22	.	.	PUNCT
ajlm-1597	65	1	this	this	PRON
ajlm-1597	65	2	has	have	VERB
ajlm-1597	65	3	the	the	DET
ajlm-1597	65	4	potential	potential	NOUN
ajlm-1597	65	5	to	to	PART
ajlm-1597	65	6	result	result	VERB
ajlm-1597	65	7	in	in	ADP
ajlm-1597	65	8	inappropriate	inappropriate	ADJ
ajlm-1597	65	9	antimicrobial	antimicrobial	ADJ
ajlm-1597	65	10	therapy	therapy	NOUN
ajlm-1597	65	11	and	and	CCONJ
ajlm-1597	65	12	adverse	adverse	ADJ
ajlm-1597	65	13	patient	patient	ADJ
ajlm-1597	65	14	outcomes	outcome	NOUN
ajlm-1597	65	15	.	.	PUNCT
ajlm-1597	66	1	this	this	DET
ajlm-1597	66	2	extremely	extremely	ADV
ajlm-1597	66	3	high	high	ADJ
ajlm-1597	66	4	vme	vme	PROPN
ajlm-1597	66	5	contrast	contrast	NOUN
ajlm-1597	66	6	with	with	ADP
ajlm-1597	66	7	previous	previous	ADJ
ajlm-1597	66	8	studies	study	NOUN
ajlm-1597	66	9	mentioned	mention	VERB
ajlm-1597	66	10	earlier	early	ADV
ajlm-1597	66	11	.	.	PUNCT
ajlm-1597	67	1	however	however	ADV
ajlm-1597	67	2	,	,	PUNCT
ajlm-1597	67	3	those	those	DET
ajlm-1597	67	4	studies	study	NOUN
ajlm-1597	67	5	included	include	VERB
ajlm-1597	67	6	fewer	few	ADJ
ajlm-1597	67	7	a.	a.	NOUN
ajlm-1597	67	8	baumannii	baumannii	PROPN
ajlm-1597	67	9	isolates	isolate	NOUN
ajlm-1597	67	10	compared	compare	VERB
ajlm-1597	67	11	to	to	ADP
ajlm-1597	67	12	our	our	PRON
ajlm-1597	67	13	study	study	NOUN
ajlm-1597	67	14	.	.	PUNCT
ajlm-1597	68	1	in	in	ADP
ajlm-1597	68	2	addition	addition	NOUN
ajlm-1597	68	3	to	to	ADP
ajlm-1597	68	4	the	the	DET
ajlm-1597	68	5	unacceptable	unacceptable	ADJ
ajlm-1597	68	6	vme	vme	PROPN
ajlm-1597	68	7	rate	rate	NOUN
ajlm-1597	68	8	,	,	PUNCT
ajlm-1597	68	9	the	the	DET
ajlm-1597	68	10	categorical	categorical	ADJ
ajlm-1597	68	11	agreement	agreement	NOUN
ajlm-1597	68	12	,	,	PUNCT
ajlm-1597	68	13	essential	essential	ADJ
ajlm-1597	68	14	agreement	agreement	NOUN
ajlm-1597	68	15	and	and	CCONJ
ajlm-1597	68	16	the	the	DET
ajlm-1597	68	17	major	major	ADJ
ajlm-1597	68	18	error	error	NOUN
ajlm-1597	68	19	rates	rate	NOUN
ajlm-1597	68	20	with	with	ADP
ajlm-1597	68	21	vitek	vitek	PROPN
ajlm-1597	68	22	®	®	PROPN
ajlm-1597	68	23	2	2	NUM
ajlm-1597	68	24	were	be	AUX
ajlm-1597	68	25	also	also	ADV
ajlm-1597	68	26	unacceptable	unacceptable	ADJ
ajlm-1597	68	27	according	accord	VERB
ajlm-1597	68	28	to	to	ADP
ajlm-1597	68	29	the	the	DET
ajlm-1597	68	30	fda	fda	PROPN
ajlm-1597	68	31	requirements	requirement	NOUN
ajlm-1597	68	32	for	for	ADP
ajlm-1597	68	33	an	an	DET
ajlm-1597	68	34	ast	ast	NOUN
ajlm-1597	68	35	testing	testing	NOUN
ajlm-1597	68	36	platform.11	platform.11	ADJ
ajlm-1597	68	37	attempts	attempt	NOUN
ajlm-1597	68	38	to	to	PART
ajlm-1597	68	39	make	make	VERB
ajlm-1597	68	40	mbmd	mbmd	NOUN
ajlm-1597	68	41	more	more	ADV
ajlm-1597	68	42	readily	readily	ADV
ajlm-1597	68	43	available	available	ADJ
ajlm-1597	68	44	and	and	CCONJ
ajlm-1597	68	45	easier	easy	ADJ
ajlm-1597	68	46	to	to	PART
ajlm-1597	68	47	implement	implement	VERB
ajlm-1597	68	48	until	until	SCONJ
ajlm-1597	68	49	other	other	ADJ
ajlm-1597	68	50	testing	testing	NOUN
ajlm-1597	68	51	options	option	NOUN
ajlm-1597	68	52	become	become	VERB
ajlm-1597	68	53	available	available	ADJ
ajlm-1597	68	54	are	be	AUX
ajlm-1597	68	55	required	require	VERB
ajlm-1597	68	56	.	.	PUNCT
ajlm-1597	69	1	matuschek	matuschek	PROPN
ajlm-1597	69	2	et	et	PROPN
ajlm-1597	69	3	al	al	PROPN
ajlm-1597	69	4	.	.	PROPN
ajlm-1597	69	5	evaluated	evaluate	VERB
ajlm-1597	69	6	five	five	NUM
ajlm-1597	69	7	recently	recently	ADV
ajlm-1597	69	8	developed	develop	VERB
ajlm-1597	69	9	commercial	commercial	ADJ
ajlm-1597	69	10	bmd	bmd	PROPN
ajlm-1597	69	11	systems	systems	PROPN
ajlm-1597	69	12	–	–	PUNCT
ajlm-1597	69	13	sempa1	sempa1	NOUN
ajlm-1597	69	14	(	(	PUNCT
ajlm-1597	69	15	sensititre	sensititre	NOUN
ajlm-1597	69	16	™	™	ADJ
ajlm-1597	69	17	custom	custom	NOUN
ajlm-1597	69	18	plate	plate	NOUN
ajlm-1597	69	19	[	[	X
ajlm-1597	69	20	thermo	thermo	NOUN
ajlm-1597	69	21	fisher	fisher	PROPN
ajlm-1597	69	22	scientific	scientific	PROPN
ajlm-1597	69	23	,	,	PUNCT
ajlm-1597	69	24	east	east	NOUN
ajlm-1597	69	25	grinstead	grinstead	NOUN
ajlm-1597	69	26	,	,	PUNCT
ajlm-1597	69	27	united	united	ADJ
ajlm-1597	69	28	kingdom	kingdom	PROPN
ajlm-1597	69	29	]	]	PUNCT
ajlm-1597	69	30	,	,	PUNCT
ajlm-1597	69	31	micronaut	micronaut	PROPN
ajlm-1597	69	32	-	-	PUNCT
ajlm-1597	69	33	s	s	X
ajlm-1597	69	34	and	and	CCONJ
ajlm-1597	69	35	micronaut	micronaut	ADJ
ajlm-1597	69	36	mic	mic	ADJ
ajlm-1597	69	37	-	-	PUNCT
ajlm-1597	69	38	strip	strip	NOUN
ajlm-1597	70	1	[	[	X
ajlm-1597	70	2	merlin	merlin	PROPN
ajlm-1597	70	3	diagnostika	diagnostika	PROPN
ajlm-1597	70	4	gmbh	gmbh	PROPN
ajlm-1597	70	5	,	,	PUNCT
ajlm-1597	70	6	bornheim	bornheim	PROPN
ajlm-1597	70	7	,	,	PUNCT
ajlm-1597	70	8	germany	germany	PROPN
ajlm-1597	70	9	]	]	PUNCT
ajlm-1597	70	10	,	,	PUNCT
ajlm-1597	70	11	sensitest	sensit	ADJ
ajlm-1597	70	12	™	™	ADJ
ajlm-1597	70	13	[	[	X
ajlm-1597	70	14	liofilchem	liofilchem	NOUN
ajlm-1597	70	15	,	,	PUNCT
ajlm-1597	70	16	roseto	roseto	NOUN
ajlm-1597	70	17	degli	degli	NOUN
ajlm-1597	70	18	abruzzi	abruzzi	NOUN
ajlm-1597	70	19	,	,	PUNCT
ajlm-1597	70	20	italy	italy	PROPN
ajlm-1597	70	21	]	]	PUNCT
ajlm-1597	70	22	and	and	CCONJ
ajlm-1597	70	23	umic	umic	ADJ
ajlm-1597	70	24	[	[	X
ajlm-1597	70	25	biocentric	biocentric	ADJ
ajlm-1597	70	26	,	,	PUNCT
ajlm-1597	70	27	bandol	bandol	ADJ
ajlm-1597	70	28	,	,	PUNCT
ajlm-1597	70	29	france]).12	france]).12	NOUN
ajlm-1597	70	30	these	these	PRON
ajlm-1597	70	31	were	be	AUX
ajlm-1597	70	32	evaluated	evaluate	VERB
ajlm-1597	70	33	against	against	ADP
ajlm-1597	70	34	mbmd	mbmd	NOUN
ajlm-1597	70	35	using	use	VERB
ajlm-1597	70	36	various	various	ADJ
ajlm-1597	70	37	gram	gram	NOUN
ajlm-1597	70	38	-	-	PUNCT
ajlm-1597	70	39	negative	negative	ADJ
ajlm-1597	70	40	organisms	organism	NOUN
ajlm-1597	70	41	including	include	VERB
ajlm-1597	70	42	22	22	NUM
ajlm-1597	70	43	acinetobacter	acinetobacter	ADV
ajlm-1597	70	44	spp	spp	NOUN
ajlm-1597	70	45	isolates.12	isolates.12	PROPN
ajlm-1597	70	46	they	they	PRON
ajlm-1597	70	47	demonstrated	demonstrate	VERB
ajlm-1597	70	48	overall	overall	ADV
ajlm-1597	70	49	better	well	ADJ
ajlm-1597	70	50	performance	performance	NOUN
ajlm-1597	70	51	compared	compare	VERB
ajlm-1597	70	52	to	to	ADP
ajlm-1597	70	53	our	our	PRON
ajlm-1597	70	54	findings	finding	NOUN
ajlm-1597	70	55	with	with	ADP
ajlm-1597	70	56	vitek	vitek	PROPN
ajlm-1597	70	57	®	®	PROPN
ajlm-1597	70	58	2	2	NUM
ajlm-1597	70	59	.	.	PUNCT
ajlm-1597	71	1	the	the	DET
ajlm-1597	71	2	majority	majority	NOUN
ajlm-1597	71	3	of	of	ADP
ajlm-1597	71	4	the	the	DET
ajlm-1597	71	5	platforms	platform	NOUN
ajlm-1597	71	6	had	have	VERB
ajlm-1597	71	7	acceptable	acceptable	ADJ
ajlm-1597	71	8	categorical	categorical	ADJ
ajlm-1597	71	9	agreement	agreement	NOUN
ajlm-1597	71	10	and	and	CCONJ
ajlm-1597	71	11	essential	essential	ADJ
ajlm-1597	71	12	agreement	agreement	NOUN
ajlm-1597	71	13	(	(	PUNCT
ajlm-1597	71	14	>	>	X
ajlm-1597	71	15	90	90	NUM
ajlm-1597	71	16	%	%	NOUN
ajlm-1597	71	17	)	)	PUNCT
ajlm-1597	71	18	,	,	PUNCT
ajlm-1597	71	19	with	with	ADP
ajlm-1597	71	20	significantly	significantly	ADV
ajlm-1597	71	21	lower	low	ADJ
ajlm-1597	71	22	error	error	NOUN
ajlm-1597	71	23	rates	rate	NOUN
ajlm-1597	71	24	than	than	SCONJ
ajlm-1597	71	25	obtained	obtain	VERB
ajlm-1597	71	26	in	in	ADP
ajlm-1597	71	27	this	this	DET
ajlm-1597	71	28	study	study	NOUN
ajlm-1597	71	29	.	.	PUNCT
ajlm-1597	72	1	interestingly	interestingly	ADV
ajlm-1597	72	2	,	,	PUNCT
ajlm-1597	72	3	there	there	PRON
ajlm-1597	72	4	were	be	VERB
ajlm-1597	72	5	no	no	DET
ajlm-1597	72	6	vmes	vme	NOUN
ajlm-1597	72	7	detected	detect	VERB
ajlm-1597	72	8	in	in	ADP
ajlm-1597	72	9	the	the	DET
ajlm-1597	72	10	a.	a.	NOUN
ajlm-1597	72	11	baumannii	baumannii	PROPN
ajlm-1597	72	12	isolates	isolate	NOUN
ajlm-1597	72	13	.	.	PUNCT
ajlm-1597	73	1	however	however	ADV
ajlm-1597	73	2	,	,	PUNCT
ajlm-1597	73	3	this	this	DET
ajlm-1597	73	4	study	study	NOUN
ajlm-1597	73	5	tested	test	VERB
ajlm-1597	73	6	fewer	few	ADJ
ajlm-1597	73	7	isolates	isolate	NOUN
ajlm-1597	73	8	than	than	ADP
ajlm-1597	73	9	our	our	PRON
ajlm-1597	73	10	study	study	NOUN
ajlm-1597	73	11	.	.	PUNCT
ajlm-1597	74	1	these	these	DET
ajlm-1597	74	2	methods	method	NOUN
ajlm-1597	74	3	may	may	AUX
ajlm-1597	74	4	offer	offer	VERB
ajlm-1597	74	5	an	an	DET
ajlm-1597	74	6	alternative	alternative	NOUN
ajlm-1597	74	7	to	to	ADP
ajlm-1597	74	8	mbmd	mbmd	NOUN
ajlm-1597	74	9	and	and	CCONJ
ajlm-1597	74	10	further	further	ADJ
ajlm-1597	74	11	research	research	NOUN
ajlm-1597	74	12	on	on	ADP
ajlm-1597	74	13	their	their	PRON
ajlm-1597	74	14	performance	performance	NOUN
ajlm-1597	74	15	is	be	AUX
ajlm-1597	74	16	required	require	VERB
ajlm-1597	74	17	.	.	PUNCT
ajlm-1597	75	1	limitations	limitation	NOUN
ajlm-1597	75	2	only	only	ADV
ajlm-1597	75	3	a	a	DET
ajlm-1597	75	4	small	small	ADJ
ajlm-1597	75	5	number	number	NOUN
ajlm-1597	75	6	of	of	ADP
ajlm-1597	75	7	colistin	colistin	NOUN
ajlm-1597	75	8	-	-	PUNCT
ajlm-1597	75	9	resistant	resistant	ADJ
ajlm-1597	75	10	isolates	isolate	NOUN
ajlm-1597	75	11	were	be	AUX
ajlm-1597	75	12	obtained	obtain	VERB
ajlm-1597	75	13	for	for	ADP
ajlm-1597	75	14	the	the	DET
ajlm-1597	75	15	study	study	NOUN
ajlm-1597	75	16	.	.	PUNCT
ajlm-1597	76	1	analysis	analysis	NOUN
ajlm-1597	76	2	of	of	ADP
ajlm-1597	76	3	larger	large	ADJ
ajlm-1597	76	4	numbers	number	NOUN
ajlm-1597	76	5	of	of	ADP
ajlm-1597	76	6	resistant	resistant	ADJ
ajlm-1597	76	7	isolates	isolate	NOUN
ajlm-1597	76	8	with	with	ADP
ajlm-1597	76	9	wider	wide	ADJ
ajlm-1597	76	10	mic	mic	ADJ
ajlm-1597	76	11	distribution	distribution	NOUN
ajlm-1597	76	12	is	be	AUX
ajlm-1597	76	13	required	require	VERB
ajlm-1597	76	14	to	to	PART
ajlm-1597	76	15	confirm	confirm	VERB
ajlm-1597	76	16	our	our	PRON
ajlm-1597	76	17	finding	finding	NOUN
ajlm-1597	76	18	of	of	ADP
ajlm-1597	76	19	high	high	ADJ
ajlm-1597	76	20	vmes	vme	NOUN
ajlm-1597	76	21	.	.	PUNCT
ajlm-1597	77	1	conclusion	conclusion	NOUN
ajlm-1597	77	2	based	base	VERB
ajlm-1597	77	3	on	on	ADP
ajlm-1597	77	4	the	the	DET
ajlm-1597	77	5	results	result	NOUN
ajlm-1597	77	6	of	of	ADP
ajlm-1597	77	7	this	this	DET
ajlm-1597	77	8	study	study	NOUN
ajlm-1597	77	9	,	,	PUNCT
ajlm-1597	77	10	vitek	vitek	PROPN
ajlm-1597	77	11	®	®	PROPN
ajlm-1597	77	12	2	2	NUM
ajlm-1597	77	13	is	be	AUX
ajlm-1597	77	14	not	not	PART
ajlm-1597	77	15	an	an	DET
ajlm-1597	77	16	alternative	alternative	NOUN
ajlm-1597	77	17	for	for	ADP
ajlm-1597	77	18	mbmd	mbmd	NOUN
ajlm-1597	77	19	for	for	ADP
ajlm-1597	77	20	colistin	colistin	NOUN
ajlm-1597	77	21	ast	ast	PROPN
ajlm-1597	77	22	in	in	ADP
ajlm-1597	77	23	our	our	PRON
ajlm-1597	77	24	setting	setting	NOUN
ajlm-1597	77	25	.	.	PUNCT
ajlm-1597	78	1	further	further	ADJ
ajlm-1597	78	2	studies	study	NOUN
ajlm-1597	78	3	are	be	AUX
ajlm-1597	78	4	required	require	VERB
ajlm-1597	78	5	to	to	PART
ajlm-1597	78	6	determine	determine	VERB
ajlm-1597	78	7	if	if	SCONJ
ajlm-1597	78	8	the	the	DET
ajlm-1597	78	9	commercially	commercially	ADV
ajlm-1597	78	10	available	available	ADJ
ajlm-1597	78	11	colistin	colistin	PROPN
ajlm-1597	78	12	bmd	bmd	PROPN
ajlm-1597	78	13	methods	method	NOUN
ajlm-1597	78	14	are	be	AUX
ajlm-1597	78	15	a	a	DET
ajlm-1597	78	16	cost	cost	NOUN
ajlm-1597	78	17	-	-	PUNCT
ajlm-1597	78	18	effective	effective	ADJ
ajlm-1597	78	19	option	option	NOUN
ajlm-1597	78	20	with	with	ADP
ajlm-1597	78	21	acceptable	acceptable	ADJ
ajlm-1597	78	22	analytical	analytical	ADJ
ajlm-1597	78	23	performance	performance	NOUN
ajlm-1597	78	24	.	.	PUNCT
ajlm-1597	79	1	additionally	additionally	ADV
ajlm-1597	79	2	,	,	PUNCT
ajlm-1597	79	3	the	the	DET
ajlm-1597	79	4	semi	semi	ADJ
ajlm-1597	79	5	-	-	ADJ
ajlm-1597	79	6	automated	automated	ADJ
ajlm-1597	79	7	platforms	platform	NOUN
ajlm-1597	79	8	such	such	ADJ
ajlm-1597	79	9	as	as	ADP
ajlm-1597	79	10	vitek	vitek	PROPN
ajlm-1597	79	11	®	®	PROPN
ajlm-1597	79	12	2	2	NUM
ajlm-1597	79	13	should	should	AUX
ajlm-1597	79	14	be	be	AUX
ajlm-1597	79	15	better	well	ADV
ajlm-1597	79	16	optimised	optimise	VERB
ajlm-1597	79	17	for	for	ADP
ajlm-1597	79	18	colistin	colistin	PROPN
ajlm-1597	79	19	ast	ast	PROPN
ajlm-1597	79	20	.	.	PUNCT
ajlm-1597	80	1	acknowledgements	acknowledgement	NOUN
ajlm-1597	80	2	the	the	DET
ajlm-1597	80	3	co	co	NOUN
ajlm-1597	80	4	-	-	NOUN
ajlm-1597	80	5	authors	author	NOUN
ajlm-1597	80	6	played	play	VERB
ajlm-1597	80	7	an	an	DET
ajlm-1597	80	8	invaluable	invaluable	ADJ
ajlm-1597	80	9	role	role	NOUN
ajlm-1597	80	10	in	in	ADP
ajlm-1597	80	11	completion	completion	NOUN
ajlm-1597	80	12	of	of	ADP
ajlm-1597	80	13	this	this	DET
ajlm-1597	80	14	work	work	NOUN
ajlm-1597	80	15	.	.	PUNCT
ajlm-1597	81	1	gratitude	gratitude	NOUN
ajlm-1597	81	2	also	also	ADV
ajlm-1597	81	3	goes	go	VERB
ajlm-1597	81	4	to	to	ADP
ajlm-1597	81	5	the	the	DET
ajlm-1597	81	6	employees	employee	NOUN
ajlm-1597	81	7	of	of	ADP
ajlm-1597	81	8	the	the	DET
ajlm-1597	81	9	nhls	nhls	NOUN
ajlm-1597	81	10	who	who	PRON
ajlm-1597	81	11	ensured	ensure	VERB
ajlm-1597	81	12	that	that	SCONJ
ajlm-1597	81	13	the	the	DET
ajlm-1597	81	14	data	datum	NOUN
ajlm-1597	81	15	used	use	VERB
ajlm-1597	81	16	for	for	ADP
ajlm-1597	81	17	this	this	DET
ajlm-1597	81	18	study	study	NOUN
ajlm-1597	81	19	were	be	AUX
ajlm-1597	81	20	of	of	ADP
ajlm-1597	81	21	high	high	ADJ
ajlm-1597	81	22	quality	quality	NOUN
ajlm-1597	81	23	.	.	PUNCT
ajlm-1597	82	1	competing	compete	VERB
ajlm-1597	82	2	interests	interest	NOUN
ajlm-1597	82	3	the	the	DET
ajlm-1597	82	4	authors	author	NOUN
ajlm-1597	82	5	declare	declare	VERB
ajlm-1597	82	6	that	that	SCONJ
ajlm-1597	82	7	there	there	PRON
ajlm-1597	82	8	were	be	VERB
ajlm-1597	82	9	no	no	DET
ajlm-1597	82	10	competing	compete	VERB
ajlm-1597	82	11	interests	interest	NOUN
ajlm-1597	82	12	,	,	PUNCT
ajlm-1597	82	13	financial	financial	ADJ
ajlm-1597	82	14	or	or	CCONJ
ajlm-1597	82	15	otherwise	otherwise	ADV
ajlm-1597	82	16	,	,	PUNCT
ajlm-1597	82	17	that	that	PRON
ajlm-1597	82	18	may	may	AUX
ajlm-1597	82	19	have	have	AUX
ajlm-1597	82	20	affected	affect	VERB
ajlm-1597	82	21	the	the	DET
ajlm-1597	82	22	writing	writing	NOUN
ajlm-1597	82	23	of	of	ADP
ajlm-1597	82	24	this	this	DET
ajlm-1597	82	25	article	article	NOUN
ajlm-1597	82	26	.	.	PUNCT
ajlm-1597	83	1	authors	author	NOUN
ajlm-1597	83	2	’	'	PUNCT
ajlm-1597	83	3	contributions	contribution	NOUN
ajlm-1597	83	4	v.f	v.f	PROPN
ajlm-1597	83	5	.	.	PROPN
ajlm-1597	83	6	conceptualised	conceptualise	VERB
ajlm-1597	83	7	the	the	DET
ajlm-1597	83	8	idea	idea	NOUN
ajlm-1597	83	9	of	of	ADP
ajlm-1597	83	10	the	the	DET
ajlm-1597	83	11	manuscript	manuscript	NOUN
ajlm-1597	83	12	,	,	PUNCT
ajlm-1597	83	13	was	be	AUX
ajlm-1597	83	14	the	the	DET
ajlm-1597	83	15	primary	primary	ADJ
ajlm-1597	83	16	author	author	NOUN
ajlm-1597	83	17	and	and	CCONJ
ajlm-1597	83	18	collated	collate	VERB
ajlm-1597	83	19	co	co	NOUN
ajlm-1597	83	20	-	-	NOUN
ajlm-1597	83	21	authors	author	NOUN
ajlm-1597	83	22	’	'	PUNCT
ajlm-1597	83	23	feedback	feedback	NOUN
ajlm-1597	83	24	.	.	PUNCT
ajlm-1597	84	1	t.t	t.t	PROPN
ajlm-1597	84	2	.	.	PROPN
ajlm-1597	84	3	contributed	contribute	VERB
ajlm-1597	84	4	to	to	ADP
ajlm-1597	84	5	the	the	DET
ajlm-1597	84	6	write	write	NOUN
ajlm-1597	84	7	-	-	PUNCT
ajlm-1597	84	8	up	up	NOUN
ajlm-1597	84	9	of	of	ADP
ajlm-1597	84	10	the	the	DET
ajlm-1597	84	11	article	article	NOUN
ajlm-1597	84	12	and	and	CCONJ
ajlm-1597	84	13	provided	provide	VERB
ajlm-1597	84	14	critical	critical	ADJ
ajlm-1597	84	15	feedback	feedback	NOUN
ajlm-1597	84	16	.	.	PUNCT
ajlm-1597	85	1	n.v.k	n.v.k	PROPN
ajlm-1597	85	2	.	.	PROPN
ajlm-1597	86	1	contributed	contribute	VERB
ajlm-1597	86	2	to	to	ADP
ajlm-1597	86	3	the	the	DET
ajlm-1597	86	4	write	write	NOUN
ajlm-1597	86	5	-	-	PUNCT
ajlm-1597	86	6	up	up	NOUN
ajlm-1597	86	7	of	of	ADP
ajlm-1597	86	8	the	the	DET
ajlm-1597	86	9	article	article	NOUN
ajlm-1597	86	10	and	and	CCONJ
ajlm-1597	86	11	provided	provide	VERB
ajlm-1597	86	12	critical	critical	ADJ
ajlm-1597	86	13	feedback	feedback	NOUN
ajlm-1597	86	14	.	.	PUNCT
ajlm-1597	87	1	sources	source	NOUN
ajlm-1597	87	2	of	of	ADP
ajlm-1597	87	3	support	support	NOUN
ajlm-1597	87	4	the	the	DET
ajlm-1597	87	5	authors	author	NOUN
ajlm-1597	87	6	received	receive	VERB
ajlm-1597	87	7	no	no	DET
ajlm-1597	87	8	funding	funding	NOUN
ajlm-1597	87	9	for	for	ADP
ajlm-1597	87	10	the	the	DET
ajlm-1597	87	11	research	research	NOUN
ajlm-1597	87	12	or	or	CCONJ
ajlm-1597	87	13	write	write	NOUN
ajlm-1597	87	14	-	-	PUNCT
ajlm-1597	87	15	up	up	NOUN
ajlm-1597	87	16	of	of	ADP
ajlm-1597	87	17	this	this	DET
ajlm-1597	87	18	study	study	NOUN
ajlm-1597	87	19	.	.	PUNCT
ajlm-1597	88	1	data	datum	NOUN
ajlm-1597	88	2	availability	availability	NOUN
ajlm-1597	88	3	the	the	DET
ajlm-1597	88	4	data	datum	NOUN
ajlm-1597	88	5	that	that	PRON
ajlm-1597	88	6	support	support	VERB
ajlm-1597	88	7	the	the	DET
ajlm-1597	88	8	findings	finding	NOUN
ajlm-1597	88	9	made	make	VERB
ajlm-1597	88	10	in	in	ADP
ajlm-1597	88	11	this	this	DET
ajlm-1597	88	12	study	study	NOUN
ajlm-1597	88	13	can	can	AUX
ajlm-1597	88	14	be	be	AUX
ajlm-1597	88	15	made	make	VERB
ajlm-1597	88	16	available	available	ADJ
ajlm-1597	88	17	from	from	ADP
ajlm-1597	88	18	the	the	DET
ajlm-1597	88	19	corresponding	corresponding	ADJ
ajlm-1597	88	20	author	author	NOUN
ajlm-1597	88	21	,	,	PUNCT
ajlm-1597	88	22	v.f	v.f	PROPN
ajlm-1597	88	23	.	.	PROPN
ajlm-1597	88	24	,	,	PUNCT
ajlm-1597	88	25	on	on	ADP
ajlm-1597	88	26	request	request	NOUN
ajlm-1597	88	27	.	.	PUNCT
ajlm-1597	89	1	disclaimer	disclaimer	VERB
ajlm-1597	89	2	the	the	DET
ajlm-1597	89	3	views	view	NOUN
ajlm-1597	89	4	expressed	express	VERB
ajlm-1597	89	5	in	in	ADP
ajlm-1597	89	6	this	this	DET
ajlm-1597	89	7	study	study	NOUN
ajlm-1597	89	8	are	be	AUX
ajlm-1597	89	9	those	those	PRON
ajlm-1597	89	10	of	of	ADP
ajlm-1597	89	11	the	the	DET
ajlm-1597	89	12	authors	author	NOUN
ajlm-1597	89	13	and	and	CCONJ
ajlm-1597	89	14	are	be	AUX
ajlm-1597	89	15	not	not	PART
ajlm-1597	89	16	an	an	DET
ajlm-1597	89	17	official	official	ADJ
ajlm-1597	89	18	position	position	NOUN
ajlm-1597	89	19	of	of	ADP
ajlm-1597	89	20	the	the	DET
ajlm-1597	89	21	university	university	NOUN
ajlm-1597	89	22	of	of	ADP
ajlm-1597	89	23	the	the	DET
ajlm-1597	89	24	witwatersrand	witwatersrand	NOUN
ajlm-1597	89	25	.	.	PUNCT
ajlm-1597	90	1	references	reference	NOUN
ajlm-1597	90	2	almasaudi	almasaudi	PROPN
ajlm-1597	90	3	sb	sb	PROPN
ajlm-1597	90	4	.	.	PROPN
ajlm-1597	90	5	acinetobacter	acinetobacter	PROPN
ajlm-1597	90	6	spp	spp	PROPN
ajlm-1597	90	7	.	.	PUNCT
ajlm-1597	91	1	as	as	ADP
ajlm-1597	91	2	nosocomial	nosocomial	ADJ
ajlm-1597	91	3	pathogens	pathogen	NOUN
ajlm-1597	91	4	:	:	PUNCT
ajlm-1597	91	5	epidemiology	epidemiology	NOUN
ajlm-1597	91	6	and	and	CCONJ
ajlm-1597	91	7	resistance	resistance	NOUN
ajlm-1597	91	8	features	feature	NOUN
ajlm-1597	91	9	.	.	PUNCT
ajlm-1597	92	1	saudi	saudi	PROPN
ajlm-1597	92	2	j	j	PROPN
ajlm-1597	92	3	biol	biol	PROPN
ajlm-1597	92	4	sci	sci	PROPN
ajlm-1597	92	5	.	.	PROPN
ajlm-1597	92	6	2018	2018	NUM
ajlm-1597	92	7	mar	mar	PROPN
ajlm-1597	92	8	1;25(3):586–596	1;25(3):586–596	NUM
ajlm-1597	92	9	.	.	PUNCT
ajlm-1597	93	1	https://doi.org/10.1016/j.sjbs.2016.009	https://doi.org/10.1016/j.sjbs.2016.009	PROPN
ajlm-1597	93	2	ahmed	ahmed	PROPN
ajlm-1597	93	3	ss	ss	PROPN
ajlm-1597	93	4	,	,	PUNCT
ajlm-1597	93	5	alp	alp	PROPN
ajlm-1597	93	6	e	e	PROPN
ajlm-1597	93	7	,	,	PUNCT
ajlm-1597	93	8	hopman	hopman	PROPN
ajlm-1597	93	9	j	j	PROPN
ajlm-1597	93	10	,	,	PUNCT
ajlm-1597	93	11	voss	voss	PROPN
ajlm-1597	93	12	a.	a.	PROPN
ajlm-1597	93	13	global	global	PROPN
ajlm-1597	93	14	epidemiology	epidemiology	PROPN
ajlm-1597	93	15	on	on	ADP
ajlm-1597	93	16	colistin	colistin	NOUN
ajlm-1597	93	17	-	-	PUNCT
ajlm-1597	93	18	resistant	resistant	ADJ
ajlm-1597	93	19	acinetobacter	acinetobacter	ADJ
ajlm-1597	93	20	baumannii	baumannii	PROPN
ajlm-1597	93	21	.	.	PUNCT
ajlm-1597	94	1	j	j	PROPN
ajlm-1597	94	2	infect	infect	VERB
ajlm-1597	94	3	dis	dis	PROPN
ajlm-1597	94	4	ther	ther	ADV
ajlm-1597	94	5	.	.	PUNCT
ajlm-1597	95	1	2016;4(4):287	2016;4(4):287	X
ajlm-1597	95	2	.	.	PUNCT
ajlm-1597	96	1	https://doi.org/10.4172/2332-0877.1000287	https://doi.org/10.4172/2332-0877.1000287	PROPN
ajlm-1597	97	1	bakthavatchalam	bakthavatchalam	PROPN
ajlm-1597	97	2	y	y	PROPN
ajlm-1597	97	3	,	,	PUNCT
ajlm-1597	97	4	pragasam	pragasam	NOUN
ajlm-1597	97	5	a	a	PROPN
ajlm-1597	97	6	,	,	PUNCT
ajlm-1597	97	7	biswas	biswas	PROPN
ajlm-1597	97	8	i	i	PROPN
ajlm-1597	97	9	,	,	PUNCT
ajlm-1597	97	10	veeraraghavan	veeraraghavan	PROPN
ajlm-1597	97	11	b.	b.	PROPN
ajlm-1597	97	12	polymyxin	polymyxin	PROPN
ajlm-1597	97	13	susceptibility	susceptibility	PROPN
ajlm-1597	97	14	testing	testing	NOUN
ajlm-1597	97	15	,	,	PUNCT
ajlm-1597	97	16	interpretative	interpretative	ADJ
ajlm-1597	97	17	breakpoints	breakpoint	NOUN
ajlm-1597	97	18	and	and	CCONJ
ajlm-1597	97	19	resistance	resistance	NOUN
ajlm-1597	97	20	mechanisms	mechanism	NOUN
ajlm-1597	97	21	:	:	PUNCT
ajlm-1597	97	22	an	an	DET
ajlm-1597	97	23	update	update	NOUN
ajlm-1597	97	24	.	.	PUNCT
ajlm-1597	98	1	j	j	PROPN
ajlm-1597	98	2	glob	glob	PROPN
ajlm-1597	98	3	antimicrob	antimicrob	NOUN
ajlm-1597	98	4	resist	resist	VERB
ajlm-1597	98	5	.	.	PUNCT
ajlm-1597	99	1	2018;12:124–136	2018;12:124–136	NOUN
ajlm-1597	99	2	.	.	PUNCT
ajlm-1597	100	1	https://doi.org/10.1016/j.jgar.2017.09.011	https://doi.org/10.1016/j.jgar.2017.09.011	VERB
ajlm-1597	100	2	clsi	clsi	NOUN
ajlm-1597	100	3	-	-	PUNCT
ajlm-1597	100	4	eucast	eucast	NOUN
ajlm-1597	100	5	polymyxin	polymyxin	ADJ
ajlm-1597	100	6	breakpoints	breakpoint	NOUN
ajlm-1597	100	7	working	working	NOUN
ajlm-1597	100	8	group	group	NOUN
ajlm-1597	100	9	.	.	PUNCT
ajlm-1597	101	1	recommendations	recommendation	NOUN
ajlm-1597	101	2	for	for	ADP
ajlm-1597	101	3	mic	mic	ADJ
ajlm-1597	101	4	determination	determination	NOUN
ajlm-1597	101	5	of	of	ADP
ajlm-1597	101	6	colistin	colistin	NOUN
ajlm-1597	101	7	(	(	PUNCT
ajlm-1597	101	8	polymyxin	polymyxin	NOUN
ajlm-1597	101	9	e	e	NOUN
ajlm-1597	101	10	)	)	PUNCT
ajlm-1597	102	1	[	[	X
ajlm-1597	102	2	homepage	homepage	NOUN
ajlm-1597	102	3	on	on	ADP
ajlm-1597	102	4	the	the	DET
ajlm-1597	102	5	internet	internet	NOUN
ajlm-1597	102	6	]	]	PUNCT
ajlm-1597	102	7	.	.	PUNCT
ajlm-1597	103	1	eucast	eucast	NOUN
ajlm-1597	103	2	;	;	PUNCT
ajlm-1597	103	3	2016	2016	NUM
ajlm-1597	103	4	[	[	PUNCT
ajlm-1597	103	5	cited	cite	VERB
ajlm-1597	103	6	2020	2020	NUM
ajlm-1597	103	7	feb	feb	X
ajlm-1597	103	8	03	03	NUM
ajlm-1597	103	9	]	]	PUNCT
ajlm-1597	103	10	.	.	PUNCT
ajlm-1597	104	1	available	available	ADJ
ajlm-1597	104	2	from	from	ADP
ajlm-1597	104	3	:	:	PUNCT
ajlm-1597	104	4	http://www.eucast.org/fileadmin/src/media/pdfs/eucast_files/general_documents/recommendations_for_mic_determination_of_colistin_march_2016.pdf	http://www.eucast.org/fileadmin/src/media/pdfs/eucast_files/general_documents/recommendations_for_mic_determination_of_colistin_march_2016.pdf	NOUN
ajlm-1597	104	5	poirel	poirel	PROPN
ajlm-1597	104	6	l	l	PROPN
ajlm-1597	104	7	,	,	PUNCT
ajlm-1597	104	8	jayol	jayol	PROPN
ajlm-1597	104	9	a	a	PRON
ajlm-1597	104	10	,	,	PUNCT
ajlm-1597	104	11	nordmann	nordmann	PROPN
ajlm-1597	104	12	p.	p.	NOUN
ajlm-1597	104	13	polymyxins	polymyxin	NOUN
ajlm-1597	104	14	:	:	PUNCT
ajlm-1597	104	15	antibacterial	antibacterial	ADJ
ajlm-1597	104	16	activity	activity	NOUN
ajlm-1597	104	17	,	,	PUNCT
ajlm-1597	104	18	susceptibility	susceptibility	NOUN
ajlm-1597	104	19	testing	testing	NOUN
ajlm-1597	104	20	,	,	PUNCT
ajlm-1597	104	21	and	and	CCONJ
ajlm-1597	104	22	resistance	resistance	NOUN
ajlm-1597	104	23	mechanisms	mechanism	NOUN
ajlm-1597	104	24	encoded	encode	VERB
ajlm-1597	104	25	by	by	ADP
ajlm-1597	104	26	plasmids	plasmid	NOUN
ajlm-1597	104	27	or	or	CCONJ
ajlm-1597	104	28	chromosomes	chromosome	NOUN
ajlm-1597	104	29	.	.	PUNCT
ajlm-1597	105	1	clin	clin	PROPN
ajlm-1597	105	2	microbiol	microbiol	PROPN
ajlm-1597	105	3	rev	rev	VERB
ajlm-1597	105	4	.	.	PROPN
ajlm-1597	105	5	2017	2017	NUM
ajlm-1597	105	6	apr	apr	NOUN
ajlm-1597	105	7	1;30(2):557–596	1;30(2):557–596	NUM
ajlm-1597	105	8	.	.	PUNCT
ajlm-1597	106	1	https://doi.org/10.1128/cmr.00064-16	https://doi.org/10.1128/cmr.00064-16	PROPN
ajlm-1597	106	2	dafopoulou	dafopoulou	PROPN
ajlm-1597	106	3	k	k	PROPN
ajlm-1597	106	4	,	,	PUNCT
ajlm-1597	106	5	zarkotou	zarkotou	PROPN
ajlm-1597	106	6	o	o	NOUN
ajlm-1597	106	7	,	,	PUNCT
ajlm-1597	106	8	dimitroulia	dimitroulia	PROPN
ajlm-1597	106	9	e	e	PROPN
ajlm-1597	106	10	,	,	PUNCT
ajlm-1597	106	11	et	et	PROPN
ajlm-1597	106	12	al	al	PROPN
ajlm-1597	106	13	.	.	PROPN
ajlm-1597	106	14	comparative	comparative	ADJ
ajlm-1597	106	15	evaluation	evaluation	NOUN
ajlm-1597	106	16	of	of	ADP
ajlm-1597	106	17	colistin	colistin	NOUN
ajlm-1597	106	18	susceptibility	susceptibility	NOUN
ajlm-1597	106	19	testing	testing	NOUN
ajlm-1597	106	20	methods	method	NOUN
ajlm-1597	106	21	among	among	ADP
ajlm-1597	106	22	carbapenem	carbapenem	NOUN
ajlm-1597	106	23	-	-	PUNCT
ajlm-1597	106	24	nonsusceptible	nonsusceptible	ADJ
ajlm-1597	106	25	klebsiella	klebsiella	NOUN
ajlm-1597	106	26	pneumoniae	pneumoniae	NOUN
ajlm-1597	106	27	and	and	CCONJ
ajlm-1597	106	28	acinetobacter	acinetobacter	ADV
ajlm-1597	106	29	baumannii	baumannii	ADJ
ajlm-1597	106	30	clinical	clinical	ADJ
ajlm-1597	106	31	isolates	isolate	NOUN
ajlm-1597	106	32	.	.	PUNCT
ajlm-1597	107	1	antimicrob	antimicrob	PROPN
ajlm-1597	107	2	agents	agents	PROPN
ajlm-1597	107	3	chemother	chemother	PROPN
ajlm-1597	107	4	.	.	PUNCT
ajlm-1597	108	1	2015	2015	NUM
ajlm-1597	108	2	aug	aug	PROPN
ajlm-1597	108	3	1;59(8):4625–4630	1;59(8):4625–4630	NUM
ajlm-1597	108	4	.	.	PUNCT
ajlm-1597	109	1	https://doi.org/10.1128/aac.00868-15	https://doi.org/10.1128/aac.00868-15	PROPN
ajlm-1597	109	2	lo	lo	PROPN
ajlm-1597	109	3	-	-	PUNCT
ajlm-1597	109	4	ten	ten	NUM
ajlm-1597	109	5	-	-	PUNCT
ajlm-1597	109	6	foe	foe	NOUN
ajlm-1597	109	7	jr	jr	PROPN
ajlm-1597	109	8	,	,	PUNCT
ajlm-1597	109	9	de	de	PROPN
ajlm-1597	109	10	smet	smet	PROPN
ajlm-1597	109	11	am	am	PROPN
ajlm-1597	109	12	,	,	PUNCT
ajlm-1597	109	13	diederen	diederen	PROPN
ajlm-1597	109	14	bm	bm	PROPN
ajlm-1597	109	15	,	,	PUNCT
ajlm-1597	109	16	kluytmans	kluytman	VERB
ajlm-1597	109	17	ja	ja	PROPN
ajlm-1597	109	18	,	,	PUNCT
ajlm-1597	109	19	van	van	PROPN
ajlm-1597	109	20	keulen	keulen	PROPN
ajlm-1597	109	21	ph	ph	PROPN
ajlm-1597	109	22	.	.	PROPN
ajlm-1597	109	23	comparative	comparative	ADJ
ajlm-1597	109	24	evaluation	evaluation	NOUN
ajlm-1597	109	25	of	of	ADP
ajlm-1597	109	26	the	the	DET
ajlm-1597	109	27	vitek	vitek	PROPN
ajlm-1597	109	28	2	2	NUM
ajlm-1597	109	29	,	,	PUNCT
ajlm-1597	109	30	disk	disk	NOUN
ajlm-1597	109	31	diffusion	diffusion	NOUN
ajlm-1597	109	32	,	,	PUNCT
ajlm-1597	109	33	etest	et	ADJ
ajlm-1597	109	34	,	,	PUNCT
ajlm-1597	109	35	broth	broth	ADJ
ajlm-1597	109	36	microdilution	microdilution	NOUN
ajlm-1597	109	37	,	,	PUNCT
ajlm-1597	109	38	and	and	CCONJ
ajlm-1597	109	39	agar	agar	NOUN
ajlm-1597	109	40	dilution	dilution	NOUN
ajlm-1597	109	41	susceptibility	susceptibility	NOUN
ajlm-1597	109	42	testing	testing	NOUN
ajlm-1597	109	43	methods	method	NOUN
ajlm-1597	109	44	for	for	ADP
ajlm-1597	109	45	colistin	colistin	NOUN
ajlm-1597	109	46	in	in	ADP
ajlm-1597	109	47	clinical	clinical	ADJ
ajlm-1597	109	48	isolates	isolate	NOUN
ajlm-1597	109	49	,	,	PUNCT
ajlm-1597	109	50	including	include	VERB
ajlm-1597	109	51	heteroresistant	heteroresistant	ADJ
ajlm-1597	109	52	enterobacter	enterobacter	ADJ
ajlm-1597	109	53	cloacae	cloacae	NOUN
ajlm-1597	109	54	and	and	CCONJ
ajlm-1597	109	55	acinetobacter	acinetobacter	ADJ
ajlm-1597	109	56	baumannii	baumannii	ADJ
ajlm-1597	109	57	strains	strain	NOUN
ajlm-1597	109	58	.	.	PUNCT
ajlm-1597	110	1	antimicrob	antimicrob	PROPN
ajlm-1597	110	2	agents	agents	PROPN
ajlm-1597	110	3	chemother	chemother	PROPN
ajlm-1597	110	4	.	.	PUNCT
ajlm-1597	111	1	2007	2007	NUM
ajlm-1597	111	2	jul	jul	PROPN
ajlm-1597	111	3	23;51(10):3726–3730	23;51(10):3726–3730	NUM
ajlm-1597	111	4	.	.	PUNCT
ajlm-1597	112	1	https://doi.org/10.1128/aac.01406-06	https://doi.org/10.1128/aac.01406-06	PROPN
ajlm-1597	112	2	piewngam	piewngam	PROPN
ajlm-1597	112	3	p	p	NOUN
ajlm-1597	112	4	,	,	PUNCT
ajlm-1597	112	5	kiratisin	kiratisin	PROPN
ajlm-1597	112	6	p.	p.	PROPN
ajlm-1597	112	7	comparative	comparative	ADJ
ajlm-1597	112	8	assessment	assessment	NOUN
ajlm-1597	112	9	of	of	ADP
ajlm-1597	112	10	antimicrobial	antimicrobial	ADJ
ajlm-1597	112	11	susceptibility	susceptibility	NOUN
ajlm-1597	112	12	testing	testing	NOUN
ajlm-1597	112	13	for	for	ADP
ajlm-1597	112	14	tigecycline	tigecycline	NOUN
ajlm-1597	112	15	and	and	CCONJ
ajlm-1597	112	16	colistin	colistin	VERB
ajlm-1597	112	17	against	against	ADP
ajlm-1597	112	18	acinetobacter	acinetobacter	ADJ
ajlm-1597	112	19	baumannii	baumannii	ADJ
ajlm-1597	112	20	clinical	clinical	ADJ
ajlm-1597	112	21	isolates	isolate	NOUN
ajlm-1597	112	22	,	,	PUNCT
ajlm-1597	112	23	including	include	VERB
ajlm-1597	112	24	multidrug	multidrug	NOUN
ajlm-1597	112	25	-	-	PUNCT
ajlm-1597	112	26	resistant	resistant	ADJ
ajlm-1597	112	27	isolates	isolate	NOUN
ajlm-1597	112	28	.	.	PUNCT
ajlm-1597	113	1	int	int	NOUN
ajlm-1597	113	2	j	j	PROPN
ajlm-1597	113	3	antimicrob	antimicrob	PROPN
ajlm-1597	113	4	agents	agent	NOUN
ajlm-1597	113	5	.	.	PUNCT
ajlm-1597	114	1	2014	2014	NUM
ajlm-1597	114	2	nov	nov	NOUN
ajlm-1597	114	3	1;44(5):396–401	1;44(5):396–401	NUM
ajlm-1597	114	4	.	.	PUNCT
ajlm-1597	115	1	https://doi.org/10.1016/j.ijantimicag.2014.06.014	https://doi.org/10.1016/j.ijantimicag.2014.06.014	PROPN
ajlm-1597	115	2	vourli	vourli	PROPN
ajlm-1597	115	3	s	s	PROPN
ajlm-1597	115	4	,	,	PUNCT
ajlm-1597	115	5	dafopoulou	dafopoulou	ADJ
ajlm-1597	115	6	k	k	NOUN
ajlm-1597	115	7	,	,	PUNCT
ajlm-1597	115	8	vrioni	vrioni	NOUN
ajlm-1597	115	9	g	g	NOUN
ajlm-1597	115	10	,	,	PUNCT
ajlm-1597	115	11	tsakris	tsakris	VERB
ajlm-1597	115	12	a	a	X
ajlm-1597	115	13	,	,	PUNCT
ajlm-1597	115	14	pournaras	pournara	NOUN
ajlm-1597	115	15	s.	s.	PROPN
ajlm-1597	115	16	evaluation	evaluation	NOUN
ajlm-1597	115	17	of	of	ADP
ajlm-1597	115	18	two	two	NUM
ajlm-1597	115	19	automated	automate	VERB
ajlm-1597	115	20	systems	system	NOUN
ajlm-1597	115	21	for	for	ADP
ajlm-1597	115	22	colistin	colistin	NOUN
ajlm-1597	115	23	susceptibility	susceptibility	NOUN
ajlm-1597	115	24	testing	testing	NOUN
ajlm-1597	115	25	of	of	ADP
ajlm-1597	115	26	carbapenem	carbapenem	NOUN
ajlm-1597	115	27	-	-	PUNCT
ajlm-1597	115	28	resistant	resistant	ADJ
ajlm-1597	115	29	acinetobacter	acinetobacter	ADJ
ajlm-1597	115	30	baumannii	baumannii	ADJ
ajlm-1597	115	31	clinical	clinical	ADJ
ajlm-1597	115	32	isolates	isolate	NOUN
ajlm-1597	115	33	.	.	PUNCT
ajlm-1597	116	1	j	j	PROPN
ajlm-1597	116	2	antimicrob	antimicrob	PROPN
ajlm-1597	116	3	chemother	chemother	PROPN
ajlm-1597	116	4	.	.	PUNCT
ajlm-1597	117	1	2017	2017	NUM
ajlm-1597	117	2	jun	jun	PROPN
ajlm-1597	117	3	12;72(9):2528–2530	12;72(9):2528–2530	NUM
ajlm-1597	117	4	.	.	PUNCT
ajlm-1597	118	1	https://doi.org/10.1093/jac/dkx186	https://doi.org/10.1093/jac/dkx186	PROPN
ajlm-1597	118	2	biomerieux	biomerieux	PROPN
ajlm-1597	118	3	.	.	PUNCT
ajlm-1597	119	1	urgent	urgent	ADJ
ajlm-1597	119	2	product	product	NOUN
ajlm-1597	119	3	correction	correction	NOUN
ajlm-1597	119	4	notice	notice	VERB
ajlm-1597	119	5	[	[	X
ajlm-1597	119	6	homepage	homepage	NOUN
ajlm-1597	119	7	on	on	ADP
ajlm-1597	119	8	the	the	DET
ajlm-1597	119	9	internet	internet	NOUN
ajlm-1597	119	10	]	]	PUNCT
ajlm-1597	119	11	.	.	PUNCT
ajlm-1597	120	1	[	[	X
ajlm-1597	120	2	cited	cite	VERB
ajlm-1597	120	3	2020	2020	NUM
ajlm-1597	120	4	mar	mar	PROPN
ajlm-1597	120	5	26	26	NUM
ajlm-1597	120	6	]	]	PUNCT
ajlm-1597	120	7	.	.	PUNCT
ajlm-1597	121	1	available	available	ADJ
ajlm-1597	121	2	from	from	ADP
ajlm-1597	121	3	:	:	PUNCT
ajlm-1597	121	4	https://www.bfarm.de/shareddocs/kundeninfos/en/08/2017/04963-17_kundeninfo_en.pdf?__blob=publicationfile&v=1	https://www.bfarm.de/shareddocs/kundeninfos/en/08/2017/04963-17_kundeninfo_en.pdf?__blob=publicationfile&v=1	PROPN
ajlm-1597	121	5	us	us	PROPN
ajlm-1597	121	6	food	food	NOUN
ajlm-1597	121	7	and	and	CCONJ
ajlm-1597	121	8	drug	drug	NOUN
ajlm-1597	121	9	administration	administration	NOUN
ajlm-1597	121	10	.	.	PUNCT
ajlm-1597	122	1	class	class	NOUN
ajlm-1597	122	2	ii	ii	PROPN
ajlm-1597	122	3	special	special	ADJ
ajlm-1597	122	4	controls	control	NOUN
ajlm-1597	122	5	guidance	guidance	NOUN
ajlm-1597	122	6	document	document	NOUN
ajlm-1597	122	7	:	:	PUNCT
ajlm-1597	122	8	antimicrobial	antimicrobial	ADJ
ajlm-1597	122	9	susceptibility	susceptibility	NOUN
ajlm-1597	122	10	test	test	NOUN
ajlm-1597	122	11	(	(	PUNCT
ajlm-1597	122	12	ast	ast	NOUN
ajlm-1597	122	13	)	)	PUNCT
ajlm-1597	122	14	systems	system	NOUN
ajlm-1597	122	15	;	;	PUNCT
ajlm-1597	122	16	guidance	guidance	NOUN
ajlm-1597	122	17	for	for	ADP
ajlm-1597	122	18	industry	industry	NOUN
ajlm-1597	122	19	and	and	CCONJ
ajlm-1597	122	20	fda	fda	PROPN
ajlm-1597	122	21	.	.	PUNCT
ajlm-1597	123	1	rockville	rockville	PROPN
ajlm-1597	123	2	,	,	PUNCT
ajlm-1597	123	3	md	md	PROPN
ajlm-1597	123	4	:	:	PUNCT
ajlm-1597	123	5	us	us	PROPN
ajlm-1597	123	6	food	food	NOUN
ajlm-1597	123	7	and	and	CCONJ
ajlm-1597	123	8	drug	drug	NOUN
ajlm-1597	123	9	administration	administration	NOUN
ajlm-1597	123	10	;	;	PUNCT
ajlm-1597	123	11	2003	2003	NUM
ajlm-1597	123	12	.	.	PUNCT
ajlm-1597	124	1	matuschek	matuschek	PROPN
ajlm-1597	124	2	e	e	PROPN
ajlm-1597	124	3	,	,	PUNCT
ajlm-1597	124	4	åhman	åhman	PROPN
ajlm-1597	124	5	j	j	PROPN
ajlm-1597	124	6	,	,	PUNCT
ajlm-1597	124	7	webster	webster	PROPN
ajlm-1597	124	8	c	c	PROPN
ajlm-1597	124	9	,	,	PUNCT
ajlm-1597	124	10	kahlmeter	kahlmeter	PROPN
ajlm-1597	124	11	g.	g.	PROPN
ajlm-1597	124	12	antimicrobial	antimicrobial	ADJ
ajlm-1597	124	13	susceptibility	susceptibility	NOUN
ajlm-1597	124	14	testing	testing	NOUN
ajlm-1597	124	15	of	of	ADP
ajlm-1597	124	16	colistin	colistin	NOUN
ajlm-1597	124	17	–	–	PUNCT
ajlm-1597	124	18	evaluation	evaluation	NOUN
ajlm-1597	124	19	of	of	ADP
ajlm-1597	124	20	seven	seven	NUM
ajlm-1597	124	21	commercial	commercial	ADJ
ajlm-1597	124	22	mic	mic	ADJ
ajlm-1597	124	23	products	product	NOUN
ajlm-1597	124	24	against	against	ADP
ajlm-1597	124	25	standard	standard	ADJ
ajlm-1597	124	26	broth	broth	ADJ
ajlm-1597	124	27	microdilution	microdilution	NOUN
ajlm-1597	124	28	for	for	ADP
ajlm-1597	124	29	escherichia	escherichia	NOUN
ajlm-1597	124	30	coli	coli	NOUN
ajlm-1597	124	31	,	,	PUNCT
ajlm-1597	124	32	klebsiella	klebsiella	NOUN
ajlm-1597	124	33	pneumoniae	pneumoniae	NOUN
ajlm-1597	124	34	,	,	PUNCT
ajlm-1597	124	35	pseudomonas	pseudomona	NOUN
ajlm-1597	124	36	aeruginosa	aeruginosa	NOUN
ajlm-1597	124	37	,	,	PUNCT
ajlm-1597	124	38	and	and	CCONJ
ajlm-1597	124	39	acinetobacter	acinetobacter	ADJ
ajlm-1597	124	40	spp	spp	NOUN
ajlm-1597	124	41	.	.	PUNCT
ajlm-1597	125	1	clin	clin	PROPN
ajlm-1597	125	2	microbiol	microbiol	PROPN
ajlm-1597	125	3	infect	infect	PROPN
ajlm-1597	125	4	.	.	PUNCT
ajlm-1597	126	1	2018	2018	NUM
ajlm-1597	126	2	aug	aug	PROPN
ajlm-1597	126	3	1;24(8):865–870	1;24(8):865–870	NUM
ajlm-1597	126	4	.	.	PUNCT
ajlm-1597	127	1	https://doi.org/10.1016/j.cmi.2017.11.020	https://doi.org/10.1016/j.cmi.2017.11.020	NOUN